Mar 2016

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.


PO BOX 106 954, AUCKLAND CITY 1143<br />

Email: info@nzoptics.co.nz Website: www.nzoptics.co.nz<br />

MARCH <strong>2016</strong><br />





TO<br />



UK OPTOMS!<br />



Go to<br />

spectrum-blog.com<br />

for all the current<br />

opportunities!<br />

With a significant shortage of optometrists being<br />

experienced across the optometry profession<br />

in metro, regional and rural areas, we’re calling<br />

all UK and Irish optometrists currently in<br />

New Zealand and Australia to talk to us. We have a<br />

wide range of opportunities for you to consider.<br />

Across the two countries this year we will open<br />

15 new stores and expand a further 65 stores<br />

with additional consulting rooms and the latest<br />

automated equipment – and we need to beef up<br />

our professional team to meet demand, as it rises.<br />

About you<br />

You’re an OCANZ qualified optometrist and already<br />

working (or due to work) for the length of your<br />

current working visa – but you would like to stay<br />

on for longer, or even permanently.<br />

We can help<br />

If that sounds like you, we should talk.<br />

Lately, more and more OCANZ qualified UK<br />

and Irish optometrists are asking us about<br />

staying in either New Zealand or Australia<br />

for the longer term and we have the<br />

roles available to make that goal a reality<br />

in both countries.<br />

Let’s get the conversation started<br />

Whatever your goal, both short and longer<br />

term, now’s the time to talk to our professional<br />

recruitment team members about the options for<br />

employed and partnership roles – they’re ready to<br />

talk to you right now.<br />

In the first instance contact Raj Sundarjee on<br />

0800 773 077 or raj.sundarjee@specsavers.com<br />

NZ Franchise<br />

System of<br />

the Year<br />

2014<br />

Retail<br />

Innovator<br />

of the Year<br />

2014<br />

Multichannel<br />

Retailer<br />

of the Year<br />

2014<br />

Roy Morgan<br />

Research<br />

No. 1 for eye tests<br />

2014<br />

FCA International<br />

Franchisor<br />

of the Year<br />

2014<br />

FCA Social<br />

Responsibility<br />

Award<br />

2014<br />

FCA Established<br />

Franchisor<br />

of the Year<br />

2013<br />

FCA Excellence<br />

in <strong>Mar</strong>keting<br />

Award Winner<br />

2013<br />

Australian<br />

Retailer<br />

of the Year<br />

2013<br />

Australian<br />

Retail Employer<br />

of the Year<br />

2013<br />

Asia-Pacific Best<br />

Retail Training<br />

Organisation<br />

2013<br />

2 NEW ZEALAND OPTICS <strong>Mar</strong>ch <strong>2016</strong>

Shamir focuses on New Zealand<br />

With a full-time New Zealand salesrepresentative<br />

now on board, a justlaunched<br />

dedicated New Zealand<br />

website and a new and improved delivery process<br />

to New Zealand, international lens company<br />

Shamir is taking on the incumbents in a bid to<br />

become one of New Zealand’s leading lens brands.<br />

“It’s exciting, but it’s challenging too,” says<br />

Donald Crichton, Shamir’s new Kiwi sales<br />

representative. “I’ve gone into some practices and<br />

they haven’t even heard of Shamir, even though<br />

globally Shamir is very well known.”<br />

Founded in 1972, Shamir Optical Industry (to<br />

use the company’s full name) is ranked among the<br />

world’s top ten progressive lens manufacturers.<br />

It employs around 1,800 people worldwide and<br />

operates two manufacturing facilities for moulds<br />

and semi-finished lenses in Israel and nine<br />

laboratories throughout the world, including one<br />

in Brisbane, which services the New Zealand and<br />

Australian markets. In 2011 Shamir attracted the<br />

attention of Essilor, which bought a 50% stake in<br />

the company, though the two continue to operate<br />

competitively. Shamir prides itself on being a<br />

research and development company, employing<br />

and developing state-of-the-art technology, and<br />

producing a very wide range of lenses, moulds and<br />

coatings.<br />

It’s this range and the company’s patented lens<br />

technologies that help set it apart from its peers,<br />

says Crichton. But it’s also the opportunity Shamir<br />

gives independent practitioners to try a new lens<br />

company that doesn’t require any obligations on<br />

their part, he says.<br />

“We can offer practitioners a wide range of<br />

products from a world leading manufacturer,<br />

which gives them a lot of choice, more options<br />

and a better price, without any tie-ins. We’re not<br />

asking for anyone to sign a contract with us for<br />

a minimum amount of sales. So Shamir offers<br />

independent practices the opportunity to be truly<br />

that, independent; they can make decisions about<br />

how they run their businesses because they can<br />

better control their margins.”<br />

Crichton, who was appointed in the second half<br />

of 2015, says Shamir commitment to him, the new<br />

New Zealand website and service and delivery<br />

processes—the lenses are made in Australia, but<br />

fitted by Read Prescription Services in Auckland—<br />

shows Shamir’s is serious about its intention to<br />

become a leading brand in New Zealand.<br />

Paul Stacey, chief executive of Shamir Australasia,<br />

says New Zealand’s been a target for a while, but<br />

the company needed to establish itself properly<br />

in Australia before it could really focus on New<br />

Zealand. “We did have one of our reps visiting every<br />

six weeks, and he broke the ground for us, but it<br />

wasn’t the best situation as he wasn’t there on<br />

the spot when people needed him…so now we are<br />

spending a lot more resources on New Zealand.”<br />

Stacey also admits it’s not going to be easy<br />

establishing a greater presence in New Zealand as<br />

the company is playing catch up, but with Donald<br />

and the service infrastructure now in place, he’s<br />

confident of gaining significant traction in the<br />

market. “Over the last few years we’ve spent<br />

millions of dollars over here so we can now supply<br />

the quality and the turnaround time that people in<br />

New Zealand expect.”<br />

Stacey says the company is particularly proud of<br />

its range and its Australian-made status, opting to<br />

invest heavily in its laboratory in Brisbane, rather<br />

than outsourcing its manufacturing to Thailand or<br />

China.<br />

“Our New Zealand customers will now have<br />

access to a whole range of products that may not<br />

have been available to them before, and we have a<br />

lot of flexibility so we can do a lot of things other<br />

companies can’t.”<br />

This includes free-form digital progressive lenses<br />

in glass, he says, adding that all Shamir’s lenses are<br />

cut digitally using the latest free-form technology<br />

even basic, single-vision lenses. “We don’t have any<br />

tools in our lab at all, so we were able to get rid of<br />

all that wasted space, saving us costs.”<br />

The company has also employed a dedicated<br />

quality controller at its Brisbane lab, to ensure<br />

everything runs smoothly and if there are any<br />

issues they are dealt with swiftly. Since he’s been<br />

employed there’s been 30% less wastage, says<br />

Stacey.<br />

Other Shamir developments include new coatings<br />

(a particular focus of the parent company over the<br />

last year): Shamir Glacier Blue UV, a completely<br />

clear lens that transmits as much light as ordinary<br />

glasses, while deflecting a significant proportion<br />

of damaging blue light; Shamir Glacier Achromatic<br />

UV, that is reported to be highly durable, scratch<br />

resistant and easy to clean, offering all the benefits<br />

of a multi-coating without that “bluey-green<br />

bloom,” says Stacy; and Shamir Glacier Plus UV,<br />

which has a scratch-resistant Bayer rating of 19.<br />

As well as coating technologies, Stacey is also<br />

focusing on marketing fashionable safety frames<br />

and lenses after Shamir purchased the majority<br />

of Perth-based safety frames company Eyres last<br />

year and combined Eyres’s frames with Shamir’s<br />

Attitude lens technology, which is designed for<br />

wrap-around frames.<br />

There’s a big market for fashionable safety frames<br />

and lenses in the as-yet-untapped small business<br />

market and even the home market, where it makes<br />

sense for the person who does the lawn-mowing<br />

to don a pair of attractive, safety sunglasses, either<br />

prescription or not, depending on what they need,<br />

says Stacey. “It’s still early days, but safety is a big<br />

focus for us both here, in Australia, and in New<br />

Zealand.”<br />

The other focus for the moment, however, is just<br />

getting the word out there and getting people to<br />

give Shamir a go, says Crichton.<br />

“My plan is to follow up on the interest that’s<br />

been generated in Shamir so far, continue to travel<br />

around New Zealand, sharing information about<br />

our products and endeavouring to make Shamir<br />

as familiar a brand to practitioners here as it is in<br />

other markets around the world.” ▀<br />

Shamir’s Paul Stacey happy to be in NZ<br />

Donald Crichton: Shamir’s new NZ rep<br />

Change is in<br />

the air<br />


Change is usually a good thing. It<br />

blows out the cobwebs, gives us new<br />

perspective and allows us to experience<br />

new things. It’s also hard.<br />

Each new term, changes to the kids’ activities<br />

throw painstakingly-designed parental<br />

chauffeuring plans out the window; technology<br />

changes can halt even the biggest companies;<br />

and staff changes mean training up someone<br />

new to understand, and hopefully enjoy, our<br />

businesses as much as we do.<br />

Therefore it’s with mixed emotions NZ Optics<br />

says goodbye to our editor Simon Eskow who’s<br />

finally ditched the media world to pursue his<br />

acting passion and a life of different deadlines<br />

and grammatical debates.<br />

In his place we welcome Jai (Jay) Breitnauer,<br />

also originally from the UK and married to a<br />

Kiwi (like yours truly), who’s been an editor,<br />

journalist, communications consultant, event<br />

manager and a charity fundraiser. Jai will be<br />

helping us get the April issue together, before<br />

joining properly at the end of <strong>Mar</strong>ch.<br />

Change is also afoot across the industry with<br />

many of the world’s talented frame designers<br />

launching new ranges. Some of those coming<br />

to New Zealand are detailed in this month’s<br />

issue. Then there’s the new and not so new<br />

ideas shared at ANZGIG <strong>2016</strong>, described by our<br />

columnist Keli Matheos as her most enjoyable<br />

conference ever. And finally, there’s exciting<br />

news on the lens front with Shamir determined<br />

to carve out its own niche in New Zealand,<br />

which will cause other waves of change.<br />

So change, it’s good, but can be tricky while<br />

you work through it. ▀<br />

Lesley Springall, publisher, NZ Optics<br />

Apology and correction to<br />

What’s coming…<br />

NZ Optics would like to apologise to Tim<br />

Way, managing director of the Ophthalmic<br />

Instrument Company, who was misquoted<br />

in the last issue of the magazine. Unfortunately an<br />

earlier draft of the article What’s coming… on p3. of<br />

NZ Optics February edition was published instead<br />

of the correct, later edition. Below is the correct<br />

version, which now also appears online:<br />

New tech affects change<br />

Technology is helping us to better understand<br />

what is going on inside the eye, significantly<br />

changing the examination room from what it was<br />

just a few years ago.<br />

“It’s definitely rapidly evolving with new<br />

technology,” says Tim Way, managing director<br />

of OIC. “Optometrists are working smarter now,<br />

allowing more time to be spent one on one with<br />

the patient in the examination room.”<br />

Technology is making the examination process<br />

faster and the use of combination units minimising<br />

the footprint required for all of the equipment.<br />

Trained ancillary staff are more commonly using<br />

combination units such as four-in-one (auto<br />

refractor/keratometer/nct/pachymetry) or<br />

combined retinal camera/OCT units to pre-screen<br />

patients. Measurement data is taken much more<br />

speedily and the patient flow streamlined through<br />

the practice. The pre-screening data gives the<br />

optometrist a starting point for refraction which<br />

speeds up the refraction process and allows for<br />

newer diagnostic technology such as OCT to be<br />

incorporated into the standard eye examination.<br />

“OCT has rapidly become ‘standard of care’ in<br />

optometry,” Way says.<br />

It remains to be seen how other technologies,<br />

such as OCT angiography, which allows<br />

visualisation of the retinal vasculature structure<br />

without the need for the injection of dyes such as<br />

fluorescein or Indocyanine green, is accepted.<br />

“OCT angiography is a real hot topic at the<br />

moment and looks very promising and exciting for<br />

the future - but it is not mainstream as yet,” Way<br />

says. “There are a lot more studies that need to<br />

come out. It is definitely an emerging technology<br />

which will continue to be refined as we understand<br />

more and more the diagnostic information that<br />

this imaging modality makes available to us.” ▀<br />

<strong>Mar</strong>ch <strong>2016</strong><br />



News<br />

in brief<br />


In the 2014-2015 year the free B4 School Check programme<br />

reached 58,000 pre-schoolers across the country or 92% of all<br />

pre-schoolers, the highest rate since the programme launched<br />

in 2008. In a statement Health Minister Jonathan Coleman said<br />

the 2015-<strong>2016</strong> year is already tracking ahead of last year’s, with<br />

increasing progress in poorer areas. The most common findings in<br />

the check were vision and hearing difficulties.<br />


One of the final articles penned by Professor Brien Holden<br />

before he died has confirmed a worrying prediction about the<br />

increasing prevalence of myopia. Recently published in the journal<br />

Ophthalmology, the paper, Global Prevalence of Myopia and High<br />

Myopia and Temporal Trends from 2000 through 2050, predicts half<br />

the world’s population will be myopes by 2050. The study combines<br />

prevalence and population data to project change over the next<br />

35 years, reporting that 1 billion people will be highly myopic (≤<br />

–5.00 D) by 2050, a five-fold increase from 2000. His last paper—<br />

which was co-authored by colleagues from the Brien Holden Vision<br />

Institute, New South Wales University and the Singapore Eye<br />

Research Institute—concludes that planning for comprehensive eye<br />

care services is required to meet this major increase in high myopia.<br />


Apple’s new version of iOS, the operating system for iPhones and<br />

iPads, is expected to reduce user-exposure to blue light. Apple has<br />

yet to confirm a release date for iOS 9.3, but the rumor mill has it<br />

that a new setting, Night Shift, will allow users to turn on a blue<br />

light reduction feature. The aim is to reduce blue light exposure at<br />

night which can affect circadian rhythms, making it difficult to fall<br />

asleep. “Night Shift uses your iOS device’s clock and geolocation to<br />

determine when it’s sunset in your location. Then it automatically<br />

shifts the colours in your display to the warmer end of the<br />

spectrum, making it easier on your eyes. In the morning, it returns<br />

the display to its regular settings.” At the time of writing, iOS 9.3 is<br />

in public beta, and you need to enable Night Shift to use it.<br />


A halometer application operated on an iPad reliably and<br />

objectively quantified the size of patient-reported halos, according<br />

to a recent study. The small, prospective study included 20<br />

subjects with a mean age of 27.7 years. The Aston halometer<br />

measured the degree of obscuration of a target from an LED<br />

glare source on an iPad 4. Letters were moved centrifugally from<br />

the LED in 0.05° increments in eight directions of orientation<br />

separated by 45° for four contrast levels. Bangerter occlusion foils<br />

in front of the right eye and occlusion of the left eye simulated<br />

monocular glare. Subjects were placed two metres from the iPad<br />

screen in a dark room and a researcher controlled the iPad from<br />

an iPhone via Bluetooth. Halo size increased significantly and<br />

predictably with differing occlusion foils and target contrasts in a<br />

pattern similar to straylight measures (P < .001).<br />


A single injection of a gene therapy construct for advanced<br />

age-related macular degeneration (AMD) has shown safety and<br />

efficacy in a small cohort. The three-year data from a phase I/<br />

IIa study on AVA-101 (also known as sFlt-1) was described<br />

recently in Ophthalmology Times by Ian Constable, professor of<br />

ophthalmology at the University of Western Australia. The idea was<br />

for a single injection to continuously secrete a therapeutic protein<br />

over an extended period and avoid the need for frequent injections<br />

in the neovascular AMD patient. Patients with wet macula who had<br />

undergone anti-vascular endothelial growth factor therapy were<br />

tested. All subjects had monthly assessments.<br />

Although the initial study involved a very small number of patients<br />

(8), the results suggest the high-dose group needed less rescue<br />

therapy than the lower-dose group. Three-year data on 32 patients<br />

enrolled in a phase IIa study will be used to confirm findings.<br />


BioLight Israeli Life Sciences, an emerging global ophthalmic company,<br />

announced the completion of a successful US clinical study designed<br />

to assess the effectiveness of its TeaRx multi-assay test in evaluating<br />

tears’ components of healthy subjects, as well as of patients suffering<br />

from dry eye syndrome (DES). Study results demonstrated sensitivity<br />

of 86%, specificity of 87% and a positive predictive value (PPV) of 87%<br />

for the TeaRx multi-assay test. The study results also demonstrated<br />

that the TeaRx multi-assay testing approach, which incorporates a<br />

combination of tear constituents originating from different locations<br />

in the eye, has the ability to provide a more robust diagnostic output<br />

than other already marketed DES tests.<br />


Pfizer announced its new leadership team for the combined<br />

Pfizer-Allergan business, following the proposed US$150 billion<br />

merger of the two companies. Allergan’s CEO Brent Saunders<br />

will become chief operating officer of the combined company<br />

reporting to current Pfizer CEO Ian Read.<br />

After the merger, which is expected to be concluded in the<br />

second half of this year, a new global specialty and consumer<br />

brands division will include Pfizer’s consumer healthcare unit<br />

and Allergan’s ophthalmology and aesthetics businesses. It will<br />

be led by Bill Meury, head of branded pharma at Allergan.<br />

The merged company will be called Pfizer PLC. ▀<br />

Silmo heads down under<br />

Silmo, the world’s leading optical<br />

exhibition company, will hold its<br />

first show in Australia at Sydney’s<br />

new International Convention Centre in<br />

Darling Harbour from <strong>Mar</strong>ch 9-11, 2017.<br />

The new show, Silmo Sydney, will be jointly<br />

managed with Sydney-based exhibition<br />

firm Expertise Events.<br />

“Silmo Sydney will be a truly international<br />

event, delivering the ‘wow’ with a new-style<br />

format,” Gary Fitz-Roy, Expertise Events’<br />

managing director, told Australia’s Insight<br />

magazine.<br />

Unlike other optical exhibitions, Silmo<br />

Sydney, will be run for the whole industry,<br />

he said.<br />

Silmo and Premiere<br />

Classe together<br />

Silmo has joined forces with the<br />

international accessory trends<br />

trade show, Premiere Classe.<br />

Silmo will include a new area dedicated<br />

to fashion accessories under the label<br />

Premiere Classe at its international show<br />

in Paris from September 23 to September<br />

26 this year, while Premiere Classe<br />

will host an eyewear designer village<br />

called “Village Silmo” at its show from<br />

September 2 at the Porte de Versailles.<br />

“Over the years, eyewear has become<br />

the ultimate fashion ‘it’ product; a<br />

must-have accessory,” say the two<br />

exhibition firms in a joint statement.<br />

“Today, many eyewear brands have<br />

witnessed a rapid growth in their<br />

distribution networks worldwide and<br />

can now no longer confine themselves<br />

to the opticians market alone. As a<br />

result, Premiere Classe and Silmo have<br />

decided to unite forces and expertise<br />

in order to showcase the creativity<br />

“An exhibition’s timing is critical and<br />

should not be determined by what suits<br />

the organiser or what suits an industry<br />

association. It should be determined by<br />

market forces. To that end, Silmo Sydney is<br />

timed to better coincide with new design<br />

and product releases from international<br />

shows and timed to meet the most<br />

important buying times of local retailers, as<br />

they re-stock and order the latest releases<br />

for the coming year.”<br />

Fitz-Roy said many exhibitions have<br />

become unnecessarily expensive as<br />

organisers add bells and whistles for their<br />

own sake rather than meet the needs of<br />

buyers and sellers.<br />

energies behind eyewear design in the<br />

entire range of accessories offered by<br />

Premiere Classe.”<br />

Premiere Classe will dedicate 300 sqm<br />

to its eyewear collections, welcoming<br />

around 30 selected labels, displayed<br />

on specially-designed stands. The<br />

village will also include a trends forum<br />

devoted to bringing inspiration to<br />

retail traders, helping them to enhance<br />

the eyewear range offered in their<br />

stores. Silmo will showcase a pop-up<br />

accessories boutique, targeting eyewear<br />

accessories, and has created a special<br />

Premiere Classe Silmo D’OR award,<br />

giving the winner a free stand at the<br />

following year’s Premiere Classe show.<br />

Silmo and Premiere Classe are both<br />

organised by the Comexposium group.<br />

* See associated story about Silmo<br />

Sydney above. ▀<br />

The Silmo and Premiere Classe team: (L to R) Boris Provost, Isabel Beuzen, Eric Lenoir, Sylvie<br />

Pourrat and Xavier Clergerie<br />

www.nzoptics.co.nz | PO Box 106954, Auckland 1143 | New Zealand<br />

For general enquiries, please email info@nzoptics.co.nz<br />

For editorial and classifieds, please contact Simon Eskow, editor, at 027 288 5401 or editor@nzoptics.co.nz.<br />

For advertising, marketing, the OIG and everything else, please contact Lesley Springall, publisher, at 027 445 3543 or<br />

lesley@nzoptics.co.nz.<br />

To submit artwork, or to query a graphic, please email kirsten.newton@outlook.co.nz and copy in Lesley.<br />

NZ Optics magazine is the industry publication for New Zealand’s ophthalmic community. It is published monthly, 11<br />

times a year, by New Zealand Optics 2015 Ltd. Copyright is held by NZ Optics 2015 Ltd. As well as the magazine and the<br />

website, NZ Optics publishes the annual New Zealand Optical Information Guide (OIG), a comprehensive listing guide<br />

that profiles the products and services of the industry. NZ Optics is an independent publication and has no affiliation<br />

with any organisations. The views expressed in this publication are not necessarily those of NZ Optics (2015) Ltd.<br />

“Silmo Sydney is priced so that it’s a costeffective<br />

part of the smallest supplier’s<br />

annual marketing budget as well as the<br />

largest. Our base price is already excellent,<br />

but with incentives based on size of space<br />

booked and which state or territory exhibitors<br />

are shipping from, it gets even better.”<br />

Bigger is not always better, however, he<br />

added, saying the new three-day show<br />

will have a maximum stand size of 180<br />

sqm and is being designed so it will appeal<br />

to international as well as Australian<br />

companies.<br />

PromoSalons, which represents Silmo in<br />

Australia, has been retained to represent<br />

Silmo Sydney internationally. Plus two<br />

advisory panels will be established to<br />

represent buyers and suppliers.<br />

The Eyewear Suppliers Panel will ensure the<br />

exhibition meets the needs from the sellers’<br />

perspective, while the Eyewear Retailers Panel<br />

will include representative optometrists,<br />

optical dispensers, ophthalmologists and<br />

independent retailers, plus representatives<br />

from the chains and others involved in the<br />

consumer category to advise about what<br />

they’d like to see to stimulate buying and<br />

visitor attendance. Their collective input<br />

will also shape the topics and format for an<br />

associated Independent Retail Conference,<br />

said Fitz-Roy. ▀<br />

Essilor<br />

achieves<br />

green gong<br />

Essilor’s state of the art R&D centre in France<br />

For the fourth consecutive year, Essilor has<br />

been included among the Global 100 Most<br />

Sustainable Corporations in the World<br />

(Global 100) Index ranking by Corporate Knights<br />

magazine, also known as “the magazine for<br />

clean capitalism”.<br />

In a statement announcing the accolade,<br />

Jayanth Bhuvaraghan, Essilor’s chief corporate<br />

mission officer, highlighted how crucial good<br />

vision is to achieving the UN Sustainable<br />

Development Goals.<br />

“Seeing well enables individuals to learn<br />

better, work better, live better... and can clearly<br />

contribute to the collective capacity to reach the<br />

UN’s 2030 global ambition. At Essilor we take<br />

this responsibility very seriously and constantly<br />

strive to improve all areas of our business<br />

that can support our main contribution to<br />

sustainable development: providing good vision<br />

to everyone, everywhere.”<br />

Essilor is part of five major social responsibility<br />

indices including FTSE4GOOD; MSCI World ESG,<br />

World SRI and Europe Low Carbon Leaders; Low<br />

Carbon 100 Europe Index; Ethibel Sustainability<br />

Indexes Excellence Europe & Global and ECPI<br />

Ethical EMU Equity and ECPI Ethical Europe<br />

Equity.<br />

The company was also recently ranked among<br />

the top 50 companies that are ‘Changing the<br />

World’ by Fortune magazine. ▀<br />

4 NEW ZEALAND OPTICS <strong>Mar</strong>ch <strong>2016</strong>

R<br />

E M<br />

A R K<br />

A B L E<br />

VISION<br />

5*<br />



• Biotrue ® ONEday lenses with HIGH DEFINITION OPTICS 1<br />

1<br />

2<br />

• Maximum moisture on the eye for end of day comfort 1,2<br />

• Shape retention better than leading daily disposable lens 3<br />

• Outstanding breathability for white, healthy eyes 4<br />

• UV blocks for sun protection 5*<br />


REFERENCES: 1. Data on File, Bausch & Lomb Inc. Results from a 21 investigator, multi-site study of Biotrue ONEday lenses, with a total of 414 eligible subjects (210 daily disposable lens wearers, 204 planned replacement lens wearers). After 7 days of wear, subjects completed an online survey. Consumers rated Biotrue ONEday<br />

lens performance across a range of attributes and compared the performance to their habitual lenses. 2. Data on File, Bausch & Lomb Inc. Twenty-two subjects participated in a randomised, double-masked, contralateral eye study to evaluate water loss of Biotrue ONEday, 1-Day ACUVUE MOIST, and 1-Day ACUVUE TruEye. After 4, 8,<br />

12, and 16 hours of wear, lenses were removed and immediately weighed (wet weight). The lenses were then completely dried and reweighed (dry weight). The percent water loss was then calculated for each lens from the wet and dry weights (Statistically signifi cant.) 3. Data on File, Bausch & Lomb Inc. Results of in vitro study in which<br />

Biotrue ONEday, 1-Day ACUVUE Moist, DAILIES AquaComfort Plus, and 1-Day ACUVUE TruEye lenses were allowed to dehydrate under the same ambient conditions of approximately 72°F with a relative humidity of 30% (Statistically signifi cant.) 4. Brennan NA. A model of oxygen fl ux through contact lenses. Cornea. 2001;20(1):104-108<br />

5. Data on File, Bausch & Lomb Inc. UV Warning – Helps protect against transmission of harmful UV radiation to the cornea and into the eye. * WARNING: UV-absorbing contact lenses are NOT substitutes for protective UV-absorbing eyewear such as UV-absorbing goggles or sunglasses because they do not completely cover the eye<br />

and surrounding area. The effectiveness of wearing UV-absorbing contact lenses in preventing or reducing the incidence of ocular disorders associated with exposure to UV light has not been established at this time. You should continue to<br />

use UV-absorbing eyewear as directed. NOTE: Long-term exposure to UV radiation is one of the risk factors associated with cataracts. Exposure is based on a number of factors such as environmental conditions (altitude, geography, cloud<br />

cover) and personal factors (extent and nature of outdoor activities). UV-blocking contact lenses help provide protection against harmful UV radiation. However, clinical studies have not been done to demonstrate that wearing UV-blocking<br />

contact lenses reduces the risk of developing cataracts or other eye disorders. Consult your eye care professional for more information. © 2013 Bausch & Lomb Incorporated. ®/TM denote trademarks of Bausch & Lomb Incorporated and its<br />

affi liates. Other product names /brand names are trademarks of their respective owners. Bausch & Lomb (NZ) Ltd c/- Bell Gully Auckland, Vero Centre, 48 Shortland Street, Auckland 1140, New Zealand. <strong>Mar</strong>keted by Radiant Health Ltd. 0508 RADIANT.<br />

<strong>Mar</strong>ch <strong>2016</strong><br />



Focus<br />

on Business<br />

RECRUITMENT DIRECTION FOR <strong>2016</strong> AND JOB<br />


Hopefully <strong>2016</strong> has kicked off with a flying<br />

start for all of you. No doubt many of you<br />

will be working on key activities for your<br />

business and, as part of this, may be focused on<br />

the best way to source and recruit the right level<br />

of expertise to join your team this year.<br />

You may recall in my last editorial (December<br />

2015) we looked at analysing the impact of a<br />

resource gap on your business. We highlighted<br />

a WOF checklist for a position description to aid<br />

in attracting, sourcing and recruiting new staff<br />

members. The next step is to plan for an effective<br />

candidate sourcing strategy to attract the right<br />

level and quality of talent to meet your business<br />

requirements. So where do you start? What<br />

challenges will you face and how and where will<br />

you recruit the best talent?<br />

Linkedin’s Global Recruiting Trends <strong>2016</strong> survey<br />

identified four key areas that could present<br />

challenges—and opportunities— for you and your<br />

hiring managers. The survey asked over 4,000<br />

professionals to highlight their key priorities and<br />

challenges.<br />

This year’s results showed a key message<br />

emerging for recruitment: the power of<br />

relationships.<br />

Here is a summary of those topics:<br />

Quality of hire<br />

This was the single most valuable performance<br />

measure for hiring managers. Organisations around<br />

the world measure quality of hire in three very<br />

different ways:<br />

••<br />

New Hire Performance Evaluation<br />

••<br />

Turnover and Retention (Australia and New<br />

Zealand key focus)<br />

••<br />

Hiring Manager Satisfaction<br />

Finding talent faster<br />

How do you do this? Social Professional networks<br />

lead the way as the top source for quality hires<br />

followed by Internet Job Boards and Employee<br />

Referral Programmes (these are seen as essential<br />

and long lasting trends).<br />

Employer branding increases<br />

Companies are now spending more on employer<br />

branding efforts. 57% of organisations in New<br />

Zealand are investing in their employer branding,<br />

for example, Wholeoranges Consulting: The<br />

Refreshingly Different Recruitment Firm.<br />

Employee retention emerges<br />

Leaders want to keep the talent they worked so<br />

hard to recruit which is why employee retention is<br />

a key priority.<br />

Overall, 39% want to focus on recruiting highly<br />

skilled staff, 32% are focused on retention of staff<br />

and 26% are focused on improving quality of hire.<br />

So with these trends in mind, consider your<br />

current recruitment approach and ask some<br />

questions: Where are you doing well and not so<br />

well? Where do you want to focus? What can<br />

you do now to incorporate these trends into<br />

your recruitment strategy? How do you measure<br />

your quality of hire? How can you find talent<br />

faster? What methods of sourcing candidates<br />

will you incorporate into your approach this<br />

year? How effective is your employer branding:<br />

does it attract the right candidates? What do<br />

you have in place to retain staff? How effective<br />

is this? What do you need to change to make<br />

it more effective? Have you got the skills inhouse<br />

to manage this effectively or do you need<br />

to consider outsourcing to an expert? What<br />

improvements can you make now?<br />

Once you decide your key direction and how you<br />

want to drive your recruitment strategy you can<br />

put some of these ideas into action. Good luck.<br />

Effective advertising<br />

A good advert is key to attracting the best<br />

candidate. Consider how your ad will stand<br />

out and what to highlight to encourage the<br />

right candidates to apply. Job seekers look for<br />

adverts that reflect the type of company and<br />

culture they wish to work for. They want to see<br />

a better opportunity than their current role.<br />


Does your advert reflect this? Make your advert<br />

motivating, welcoming and appealing. You only<br />

have a few moments to grab the job seeker’s<br />

attention. Does your advert do that?<br />

Talk to the job seeker at their level. Use “you” or<br />

“your”, rather than “we” and “our”. Make the ad<br />

inviting and welcoming. You are encouraging them<br />

to work for you so think about what would make a<br />

difference to you if you were a job seeker.<br />

Start with an appealing job title<br />

Ensure the title captures the right level of job<br />

seeker you are looking for. Be creative, informative<br />

and engaging. Use succinct words to highlight the<br />

key features of the opportunity and describe the<br />

team culture. Know your audience and what may<br />

appeal to them. Be informative. Ask what would<br />

encourage them to read on and what is it about<br />

this position that is appealing. Create brand<br />

awareness so your advert stands out and dare to<br />

be different.<br />

Employer branding<br />

Consider how to profile your company brand. Is<br />

it attracting the level candidates you are looking<br />

for? If the role is confidential this may not be<br />

appropriate.<br />

Have an Introduction in your first paragraph<br />

Highlight the key purpose of the role and how<br />

this role will add value and make an impact in<br />

the business overall. You also want to give a brief<br />

outline of the level of expertise you require. You<br />

want to encourage the prospective applicant to read<br />

on so make it interesting, upbeat and descriptive.<br />

Also include a brief summary on the company (or<br />

industry), the team and culture and why it is a great<br />

place to work. Think about why someone would<br />

leave their current job to work for you.<br />

Outline key responsibilities<br />

Bullet point key skills, tasks and areas of<br />

responsibility. List five to seven key areas to help<br />

a candidate envisage what will be expected of<br />

them. It is a summary of the key skills you have<br />

used in your job description and a description of<br />

the tasks required.<br />

List highlights and incentives<br />

Write a short paragraph outlining highlights<br />

and key benefits or incentives the successful<br />

candidate will receive. Incentives don’t have to<br />

be financial, so highlight other rewards your<br />

company offers, such as flexible working times,<br />

personal development programmes, investment<br />

in innovation, education or community<br />

involvement, events, social gatherings.<br />

Location<br />

If you wish to include the location and describe<br />

transport links to help attract candidates then do<br />

so. Is the role office-based or will the candidate be<br />

travelling?<br />

Summarise key skills and level of expertise needed<br />

What level of skill, expertise or qualifications are<br />

needed? Consider the essential skills required and<br />

what skills can be negotiated. It is worth setting<br />

clear criteria so you only attract the level and<br />

quality of candidates needed. This saves a lot of<br />

time down the track. Don’t forget your contact<br />

details: name, phone number, email etc.<br />

Finally consider where you post your advert<br />

The choices are many: company websites, local<br />

and national papers and job boards, professional<br />

networking sites such as LinkedIn, student boards,<br />

industry associations and industry-specific<br />

publications, employee referral programmes and<br />

headhunting agencies<br />

If you don’t have the time, resources or the<br />

expertise consider utilising the services of a<br />

reputable recruitment specialist to help you.<br />

Next time our focus will be on Interviewing<br />

Tips. ▀<br />

* Therese McNaughten is a director and founder<br />

of Wholeoranges Consulting Ltd, a boutique<br />

recruitment firm that provides flexible<br />

recruitment services to businesses nationwide,<br />

and a business coach for those going through<br />

career transitions. For more, contact Therese at<br />

therese@wholeoranges.co.nz or visit www.<br />

wholeoranges.co.nz.<br />

Hyperopia hurts learning<br />

A<br />

recent US study suggests an association<br />

between uncorrected hyperopia and<br />

significantly poor performance in an<br />

early-age literacy test among pre-school children,<br />

according to the US National Institutes of Health,<br />

which helped fund the research.<br />

The Vision in Preschoolers-Hyperopia in<br />

Preschoolers (VIP-HIP) study compared four and<br />

five-year-old children with uncorrected hyperopia<br />

to children with normal vision and found children<br />

with moderate hyperopia of three to six diopters<br />

did significantly worse on the Test of Preschool Early<br />

Literacy (TOPEL) than their normal-vision peers.<br />

“This study suggests that an untreated vision<br />

problem in preschool, in this case one that makes<br />

it harder for children to see things up-close, can<br />

create literacy deficits that affect grade school<br />

readiness,” says <strong>Mar</strong>yann Redford, a programme<br />

director in Collaborative Clinical Research at the<br />

National Eye Institute (NEI).<br />

Hyperopia among children is usually mild,<br />

having little impact on vision. A small number<br />

of preschool children have high hyperopia (more<br />

than six diopters) which is normally diagnosed and<br />

corrected with eyeglasses. But it’s estimated that<br />

4% to 14% of children have moderate hyperopia,<br />

which often goes undiagnosed and untreated.<br />

“Prior studies have linked uncorrected hyperopia<br />

and reading ability in school-age children,” says<br />

Dr <strong>Mar</strong>jean Taylor Kulp, distinguished professor in<br />

the College of Optometry at Ohio State University<br />

and lead author of the study. “But large-scale<br />

investigations looking at reading readiness skills<br />

hadn’t been conducted in preschool children. This<br />

study was necessary to determine whether or not,<br />

at this age, there was a link between the two.”<br />

Researchers examined 492 children and divided<br />

them into two equal-size groups: those with<br />

moderate hyperopia and those with normal<br />

vision. Participation in the study included an<br />

eye examination to determine eligibility. An<br />

educational assessor unaware of the child’s visual<br />

status administered the TOPEL.<br />

Moderate hyperopia may affect school readiness among<br />

preschoolers. Credit: NEI<br />

The results revealed significantly worse<br />

performance on the TOPEL among children with<br />

uncorrected moderate hyperopia, especially<br />

those who also had reduced near visual function<br />

(including clarity of binocular vision and depth<br />

perception). Performance was most affected in the<br />

print knowledge domain of the test, which assesses<br />

the ability to identify letters and written words.<br />

“These differences are meaningful because formal<br />

learning for many children begins in the preschool<br />

years,” says Kulp. “In addition, other research<br />

exploring the long-term effect of early deficits in<br />

literacy has shown them to be associated with<br />

future problems in learning to read and write. This<br />

makes early detection of these problems important.”<br />

“Preschool children with moderate hyperopia and<br />

decreased near vision may benefit from referral<br />

for assessment of early literacy skills,” says Elise<br />

Ciner, professor at the Pennsylvania College of<br />

Optometry at Salus University in Philadelphia, and<br />

study co-investigator. “Educational interventions<br />

for children with early deficits can lead to greater<br />

educational achievement in later years.”<br />

Further research is needed to determine<br />

whether correction of moderate hyperopia with<br />

glasses can prevent the development of deficits in<br />

early literacy skills. ▀<br />

Mortimer Hirst buys<br />

Davy & Associates<br />

Auckland-based Mortimer Hirst has acquired<br />

independent practice Davy & Associates,<br />

adding a North Shore presence to its City and<br />

St Helier’s practices.<br />

Davy & Associates’ former owner <strong>Mar</strong>tyn Davy<br />

has retired, but says the sale in some ways brings<br />

his career full circle as he began his career working<br />

for Doug Mortimer and Gene Hirst in 1975. Davy<br />

actually worked for Mortimer Hirst and then Hirst<br />

Contact Lenses, which was bought by New Zealand<br />

Optical, for more than 10 years before setting up<br />

Davy & Associates in 1988.<br />

The Shore was good to him, he says, and he has<br />

no regrets about the Davy & Associates name<br />

disappearing and becoming Mortimer Hirst,<br />

especially as Mortimer Hirst is also an independent<br />

practice, which has a strong focus on contact lenses.<br />

“I did a fair bit of contact lens work in my time, so<br />

yes, it’s quite a natural progression and it’s good for<br />

Retina NZ meeting<br />

Retina New Zealand will hold its first public<br />

meeting of <strong>2016</strong> on <strong>Mar</strong>ch 20; the highlight<br />

being a presentation by Paralympic swimmer<br />

<strong>Mar</strong>y Fisher.<br />

Fisher, 23, is a multi-medal winning Paralympic<br />

athlete, originally from Silverstream, near Upper<br />

Hutt, who has sight-loss resulting from aniridia.<br />

She has been a highly competitive swimmer<br />

for years, winning a gold medal, two silvers and<br />

a bronze in her debut at the London Summer<br />

Paralympics in 2012. Her achievements within the<br />

totally blind Paralympic category led to her being<br />

made a Member of the New Zealand Order of<br />

Merit in 2013 for services to swimming.<br />

The first Retina NZ public meeting will also<br />

include a presentation by Dr Andrea Vincent,<br />

consultant ophthalmologist at Greenlane Eye<br />

Clinic and senior lecturer in the Department of<br />

Ophthalmology at Auckland University. Vincent,<br />

a long-time volunteer with Retina NZ, is part of<br />

my customers as<br />

they get continuity<br />

and someone who<br />

knows what they<br />

are doing.”<br />

As to what’s<br />

next for Davy,<br />

he says he’s just<br />

enjoying getting<br />

used to retirement<br />

and doing a<br />

bit of house<br />

maintenance,<br />

though travel is on <strong>Mar</strong>tyn Davy<br />

the cards.<br />

Mortimer Hirst principals Grant Watters and<br />

Naomi and Alex Bicheno declined to comment on<br />

the sale, but wished Davy “all the very best with his<br />

well-earned retirement”. ▀<br />

the organising committee for the 2018 Retina<br />

International World Congress to be held in<br />

Auckland. She will provide some early insight into<br />

what exciting advances delegates to the congress<br />

may discover from presentations and interactive<br />

sessions delivered by some of the world’s leading<br />

retinal scientists.<br />

Finally, there will be a presentation on how<br />

the Greenlane Clinical Centre’s Low Vision Clinic<br />

provides solutions to the daily challenges of living<br />

with sight loss, with insight on how the team work<br />

with optometrists and ophthalmologists outside<br />

the centre to aid low vision patients in maintaining<br />

their independence.<br />

The meeting will be held at the Blind Foundation,<br />

Awhina House, 545 Parnell Road, from 1 pm. There<br />

will be time for questions with the presenters before<br />

afternoon tea at 2.30 pm. Those wishing to attend<br />

can RSVP by calling 0800 569 849 or 03 338 1559.<br />

Registration closes on <strong>Mar</strong>ch 17. ▀<br />

6 NEW ZEALAND OPTICS <strong>Mar</strong>ch <strong>2016</strong>

Rodenstock<br />

appoints BTP<br />

Rodenstock’s Porsche Design sunglasses back in NZ<br />

Rodenstock and Porche<br />

Design frames are<br />

returning to New Zealand<br />

through BTP International<br />

Designz.<br />

BTP are well-known for their<br />

exceptional service and strong<br />

history in New Zealand and<br />

as such are an ideal partner<br />

for Rodenstock, says Tim<br />

McCann, general manager of<br />

Rodenstock.<br />

“New Zealand is a market<br />

that values quality and<br />

Rodenstock is highly regarded<br />

for its German manufacturing<br />

technologies and European<br />

styling.”<br />

Rodenstock is Germany’s<br />

leading manufacturer of<br />

ophthalmic lenses and frames.<br />

Founded in 1877 by Josef<br />

Rodenstock, the company<br />

has a worldwide workforce of<br />

about 4,500 and is represented<br />

in more than 85 countries,<br />

including New Zealand. As well<br />

as Rodenstock, the company’s<br />

other brands include Rocco,<br />

Claudia Schiffer, Porsche<br />

Design, Mercedes-Benz Style,<br />

Jil Sander and sports fashion<br />

frame brand Bognor.<br />

Trish Orr, BTP director,<br />

says she’s delighted to add<br />

Rodenstock’s brands to her<br />

company’s portfolio. “BTP<br />

enriches the choice of product<br />

within the practice. We supply<br />

world-renown, quality, pointof-difference<br />

brands; beautiful,<br />

sophisticated and colourful<br />

ladies ranges; neo classic,<br />

creative, vintage and edgy and<br />

fun to wear ranges. We also have<br />

a specialised children’s range.”<br />

Full details of the Rodenstock<br />

range is available from BTP. ▀<br />

Focus becomes Bailey Nelson<br />

<strong>Mar</strong>k Humphries moves to Bailey Nelson<br />

Bailey Nelson’s new boutique in Wellington<br />

The former owner of Focus Optometrists<br />

in Wellington has joined forces with<br />

Bailey Nelson in its new boutique store<br />

in the city.<br />

<strong>Mar</strong>k Humphries closed his Taranaki Street<br />

practice, which had been in operation since<br />

1994, transferring his entire client base and<br />

the majority of his optical equipment to the<br />

new Bailey Nelson practice in Willis Street,<br />

which officially opened on December 19.<br />

“<strong>Mar</strong>k was exposed to the Bailey Nelson<br />

business in Australia and enjoyed the<br />

experience, service and product that<br />

was offered,” says James Hinsley, Bailey<br />

Nelson’s country manager. “Bailey Nelson’s<br />

commitment to providing excellent eye<br />

care and examinations in addition to our<br />

quality frames, at affordable prices, peaked<br />

his interest. Focus has joined Bailey Nelson,<br />

creating a strong practice that is customerfocused<br />

with a quality service and product<br />

backing.”<br />

By merging the practices Humphries saw<br />

an opportunity to bring “his optometric<br />

practice into the modern way of practising,”<br />

says Hinsley adding that Nelson Bailey chose<br />

Willis Street because it is a perfect location<br />

for retail, with high foot-traffic and nearby<br />

complementary businesses. “The shop is a<br />

great fit for us, with a vintage nautical flair.”<br />

The four-year-old, Australia-based Bailey<br />

Nelson business opened its first New Zealand<br />

boutique (how the company refers to its<br />

practices) in Christchurch last July at the<br />

Westfield Riccarton Shopping Centre. In<br />

addition to this and the new Wellington<br />

location, the company has also<br />

launched a Ponsonby boutique, which<br />

opened its doors on December 4.<br />

Bailey Nelson sells eyewear of its<br />

own design, shunning fashion labels<br />

and sourcing materials from around<br />

the world. It works directly with<br />

particular suppliers.<br />

“Our team is passionate about<br />

timeless styling, but conscious of<br />

not living in the past,” says Hinsley.<br />

“We’re constantly driving forward<br />

with original fits and modern<br />

colours. You could call us vintage<br />

futurism, but we prefer ‘classic with<br />

a twist’.”<br />

Hinsley says Bailey Nelson releases<br />

new optical and sunglass frames<br />

every six weeks and works with<br />

its own independent laboratory<br />

to provide affordable, highquality<br />

lenses. Their digital free<br />

form progressives begin at $395,<br />

including frame and lenses.<br />

The Willis Street boutique employs<br />

six people, including Humphries and<br />

a dispensing optician. ▀<br />

Clarity in<br />

the finest<br />

of details<br />

Focused vision.<br />

For professionals like you.<br />

Hoyalux iD WorkStyle V+ is HOYA’s<br />

latest exclusive indoor solution tailored<br />

to individual working conditions.<br />

Available in three design variations<br />

– Space, Screen and Close, offering<br />

optimal depth and width perception<br />

at both near and intermediate. And<br />

thanks to the use of HOYA’s unique<br />

Binocular Harmonization Technology ,<br />

its binocular performance is unrivalled.<br />

hoyalens.com.au/indoor<br />

<strong>Mar</strong>ch <strong>2016</strong><br />



Campaign for Hollows $5<br />

Focus on<br />

Eye Research<br />

Anterior Segment<br />





Chia A, et al. Ophthalmology <strong>2016</strong>;123:391-9<br />

Review<br />

There is an epidemic of myopia occurring<br />

throughout much of the world. This study<br />

investigated the efficacy and safety of three<br />

concentrations of topical atropine to reduce the<br />

progression of myopia.<br />

In this randomised, double-masked clinical<br />

trial, 400 children were randomised to<br />

receive atropine 0.5%, 0.1% or 0.01% once<br />

daily (randomised in a 2:2:1 ratio). Children<br />

received atropine for 24 months, after which<br />

the medication was stopped for 12 months<br />

(washout period). Children who had myopia<br />

progression of 0.5 D or more during the<br />

washout period were restarted on atropine<br />

0.01% for a further 24 months. The main<br />

outcome measures were change in spherical<br />

equivalent and axial length. The results showed<br />

that the 0.01% atropine group had the highest<br />

reduction in progression of myopia (mean<br />

change of -1.38 ±0.98 D and axial length 0.75<br />

±0.48 mm) compared to the higher doses as well<br />

as the lowest short-term side effects such as<br />

cycloplegia, mydriasis and near vision loss.<br />

Comment<br />

This study showed that low dose (0.01%)<br />

atropine is a viable treatment option for the<br />

reduction of myopia progression. A limitation<br />

is the lack of a control/placebo group. The<br />

challenge of future research will be to elucidate<br />

who would benefit most from the treatment,<br />

when treatment should be started and stopped,<br />

and whether any long-term side effects exist. The<br />

comparability and compatibility of atropine with<br />

other treatment options such as orthokeratology,<br />

dual-focus contact lenses and environment/<br />

lifestyle modification (more time outdoors, less<br />

near activities) should be investigated. The lack<br />

of a commercially available formulation of lowdose<br />

atropine currently limits its use in many<br />

parts of the world.<br />




EYES.<br />

Chu CJ, et al. Ophthalmology <strong>2016</strong>;123:316-323.<br />

Review<br />

Pseudophakic macular edema (PME) is<br />

the most frequent complication to result in<br />

impaired vision following cataract surgery. This<br />

study retrospectively investigated the PME<br />

incidence, risk factors, and impact on visual<br />

acuity in a large cohort of patients following<br />

cataract surgery. Data included diabetic<br />

status and grading of retinopathy severity.<br />

Eyes receiving prophylaxis with non-steroidal<br />

medications were excluded.<br />

The baseline incidence of PME in eyes without<br />

operative complications, diabetes, or risk<br />

factors was 1.7%, increasing to 4.0% in eyes<br />

of patients with diabetes. Eyes in which PME<br />

developed were likely to be male, older and<br />

have risk factors. Risk factors were identified<br />

as capsular rupture (relative risk, RR, 2.6),<br />

epiretinal membrane (RR, 5.6), uveitis (RR, 2.9),<br />

retinal vein occlusion (RR, 4.5), prior retinal<br />

detachment repair (RR, 3.9), diabetes with<br />

or without retinopathy (RR, 1.8) and diabetic<br />

retinopathy (RR, 6.2). High myopia, age-related<br />

macular degeneration and prostaglandin analog<br />

use were not shown to increase risk. Eyes with<br />

PME had significantly worse visual acuity at the<br />


latest measured time point (24 weeks post-op).<br />

Comment<br />

This study confirms many of the previously<br />

identified risk factors for macular edema. In<br />

particular, it reinforces the risk of PME in eyes with<br />

diabetes and shows that the risk increases almost<br />

linearly with increasing severity of retinopathy.<br />

Patients with preoperative risk factors should be<br />

identified and counselled regarding their risk,<br />

monitored closely for development of PME and<br />

prophylaxis should be considered.<br />



Labiris G, et al. J Cataract Refract Surg 2015;41:53-57.<br />

Review<br />

A perfect solution for presbyopia correction<br />

using intraocular lenses (IOLs) has yet to be<br />

established. Clinical studies of multifocal IOLs<br />

have found spectacle independence rates of<br />

up to 90%. However, satisfaction levels have<br />

been limited due to optical side effects such as<br />

haloes and glare. An alternative has been to<br />

use various levels of mono-vision, where the<br />

dominant eye is targeted for distance and the<br />

non-dominant eye for near. The targeted near<br />

vision can range from -2.50 (full monovision)<br />

to -0.75 to -1.75 (mini-monovision or blended<br />

vision). While a lower differential between<br />

the two eyes can improve patient comfort by<br />

decreasing anisometropia, the trade-off is less<br />

reading capacity as the degree of myopia in the<br />

non-dominant eye is reduced.<br />

This was a prospective, randomised trial<br />

comparing the effects of monovision with<br />

multifocal IOL implantation on patient<br />

satisfaction, spectacle independence, and<br />

dysphotopsia in patients with cataracts.<br />

Patients were randomised to monovision (n=37,<br />

targeting -0.5 D in dominant eye and -1.25 D in<br />

non-dominant eye) or bilateral, multifocal IOLs<br />

(n=38, Isert, Hoya Surgical Optics, Inc; aspheric,<br />

3-zone refractive with +3.00 D add). Both<br />

groups obtained good binocular uncorrected<br />

distance visual acuity. The multifocal group<br />

obtained better overall near vision compared to<br />

the -1.25 D target for mini-monovision. There<br />

were no differences in contrast sensitivity,<br />

stereopsis, or visual function index (VF-14)<br />

scores. Twice as many multifocal patients<br />

were spectacle free (66%) compared to minimonovision<br />

patients (34%). The monovision<br />

group had less dysphotopsias (glare, shadows).<br />

Comment<br />

This study showed mini-monovision provides<br />

less spectacle independence but also less<br />

dysphotopic side effects compared multifocal<br />

IOLs. A limitation is the evaluation of just one<br />

type of multifocal IOL. As there are many other<br />

multifocal IOL platforms (including diffractive,<br />

trifocal and extended depth of focus) which<br />

differ in the degree of near correction and<br />

reported dysphotopsias, the results of this<br />

study are not generalisable to other types of<br />

multifocal IOLs. ▀<br />

* Jay Meyer is an<br />

anterior segment<br />

clinical and<br />

research fellow at<br />

the University of<br />

Auckland.<br />

The Fred Hollows<br />

Foundation is<br />

campaigning for<br />

Australia’s Reserve bank to put<br />

the late, great philanthropist<br />

and ophthalmologist Dr Fred<br />

Hollows on the country’s five<br />

dollar bill.<br />

The Foundation has<br />

established a website for<br />

Australian residents and<br />

citizens to sign a petition to<br />

change the current image of<br />

Parliament House in Canberra to Hollows.<br />

“It’s the only note that doesn’t have a person on<br />

it,” Gabi Hollows, Fred Hollows’ widow and one<br />

of Australia’s 100 Living Treasurers, told reporters<br />

at the Sydney Opera House at the end of January,<br />

where the campaign to “Get Fred on the Fiver”<br />

was launched.<br />

“Five dollars has been used so much as a catch<br />

line for Fred — ‘give Fred Five’, ‘Fivers for Fred’ — I<br />

think it would be really lovely,” she said.<br />

The campaign has the support of a number<br />

of high profile Australians including former<br />

Australian Prime Minister Bob Hawke, Olympian<br />

Cathy Freeman and six former Australians of the<br />

Year, including cricketer Steve Waugh, author and<br />

journalist Ita Buttrose, television personality Ray<br />

<strong>Mar</strong>tin and actor Joel Edgerton.<br />

The Fred Hollows Foundation campaign page<br />

states that during Hollows’ lifetime $5 was the<br />

price of a sight-saving intraocular lens.<br />

“So Fred asked Australians to donate a fiver and<br />

help restore sight to millions around the world.<br />

The $5 note still goes a long way today, with only<br />

five of them ($25) needed to restore sight in some<br />

countries. But strangely enough, the $5 note<br />

is the only Australian bank note which doesn’t<br />

recognise a great Australian,” Foundation CEO<br />

Brian Doolan said.<br />

Fred Hollows died more than 20 years ago, but<br />

his foundation has restored the sight of more than<br />

two million people worldwide.<br />

Full details of the design will be revealed in the<br />

middle of the year. ▀<br />

Specsavers backs NZ<br />

rugby refs<br />

Specsavers has signed a three-year<br />

partnership with New Zealand Rugby<br />

(NZR) to sponsor the country’s Super Rugby<br />

referees.<br />

All high-performance referees will have regular<br />

comprehensive eye examinations at Specsavers<br />

as part of their pre-season preparation and will<br />

don a new branded strip at Super Rugby matches.<br />

“It’s a great match for referees,” said Neil<br />

Sorensen, NZR’s general manager, rugby.<br />

“At the pace and energy that today’s modern<br />

professional rugby is played, referees have to be<br />

able to keep up and they need to be in tip-top<br />

condition. That includes having perfect eyesight<br />

to make all the tough calls they have to make<br />

throughout each game.”<br />

Sorenson acknowledged that referees get a<br />

lot of stick for the things they see – or don’t see<br />

– which is why this partnership sends a good<br />

message to everyone, that getting your eyes<br />

checked is important, he said.<br />

All New Zealand professional referees will be<br />

examined before their first match of the season<br />

and then annually.<br />

The deal was celebrated at a launch event at<br />

Specsavers Queen Street in Auckland in February<br />

with professional referees Nick Briant, Mike<br />

Fraser and Brendon Pickerill, who all got their<br />

eyes tested at the store as part of the launch.<br />

The three referees – who run, on average, seven<br />

kilometres a game and make hundreds of splitsecond<br />

decisions - also showcased their visual<br />

and mental acuity in-store by using the latest<br />

Fitlight training technology, a unique, wireless<br />

reaction-training system, which improves<br />

reaction times and peripheral vision.<br />

Brendan Thompson, Specsavers NZ retail<br />

director, said the company had a long history<br />

of sports partnerships and was committed to<br />

ensuring New Zealand’s top referees had the best<br />

service and technology.<br />

Investec Super Rugby kicked off on February 26<br />

with the Blues taking on the Highlanders at<br />

Eden Park. ▀<br />

Super Rugby referees Brendon Pickerill, Mike Fraser and Nick Briant in their new strip<br />

Grand Rounds start<br />

Eye Doctors’ first Grand Rounds for the year is on <strong>Mar</strong>ch 23 at the Novotel Hotel in Auckland. The<br />

keynote speaker is Dr <strong>Mar</strong>k Donaldson who will be talking about cataract and glaucoma. Dr Andrew<br />

Riley will be presenting a case study on VEGF inhibitors made easy; Dr Shuan Dai will be presenting a<br />

case study on a teenager with unnecessary visual loss; and Dr Penny McAllum will be discussing sulcoflex<br />

piggyback intraocular lenses for refractive surprise after cataract surgery. Drinks and light refreshments<br />

will be served from 5.45pm, while the Grand Round presentations start promptly at 6.30pm. To register<br />

your interest please call 09 520 9689 or email: reception@eyedoctors.co.nz ▀<br />

8 NEW ZEALAND OPTICS <strong>Mar</strong>ch <strong>2016</strong>

Get your skis on: Snowvision returns<br />

Combine skiing and learning at Snowvision <strong>2016</strong> in Queenstown this August<br />

Registration for the <strong>2016</strong> Snowvision Down<br />

Under Conference opens in mid-April. If<br />

history is any clue, the spaces will go fast.<br />

The popular biennial event offers more than<br />

30 hours of continuing education credits, with<br />

lectures, workshops and clinical seminars<br />

featuring local and international speakers.<br />

Registration is strictly limited to 100 delegates.<br />

Traditionally, 50% of spaces are taken within the<br />

first day of registration.<br />

Snowvision Down Under will be held at<br />

Queenstown’s Crowne Plaza from August 3 to<br />

August 6. This year’s programme will include<br />

presentations on neuro-ophthalmic disease, dry<br />

eye, glaucoma management, paediatric contact<br />

lens fitting, multiple sclerosis, neuroscience,<br />

nutrition and the eye, and eye care innovations<br />

in the developing world. Therapeutic optometrist<br />

Richard Johnson will take over the role of quiz<br />

master for what has been known for 20 years as<br />

Gordon Sanderson’s famous pathology quiz.<br />

The conference, organised by Grant Watters,<br />

Catherine Small, Hamish Caithness and Dave<br />

Robinson, promises to be an outstanding<br />

educational event and social function. It kicks off<br />

with an evening cocktail soiree and concludes<br />

with a steamship cruise and dinner at Walter<br />

Peak High Country Farm. Other social events<br />

includes dinner at Gibbston Valley Winery, a ski<br />

race and BBQ lunch at Coronet Peak ski field,<br />

and the CR Surfacing Go-Kart Championship at<br />

Highlands Motorsport Park. There will also be an<br />

Independent Lens Specialists golf outing at The<br />

Hills.<br />

Conference sessions will be held daily from<br />

6.30 am to 9.30 am. Clinical workshops and<br />

tutorial sessions run from 4.30 pm to 6.30 pm.<br />

The sessions are carefully scheduled to allow<br />

delegates to make the most of their time in<br />

Queenstown, whether it be enjoying the snow or<br />

a hot chocolate by an open fire.<br />

The impressive line-up of presenters includes<br />

keynote international speaker Dr Patricia Modica,<br />

assistant clinical professor at New York University’s<br />

College of Optometry; Professor Erica Fletcher from<br />

the University of Melbourne; and specialist contact<br />

lens practitioner Richard Lindsay from Australia.<br />

Local speakers include Associate Professor Jennifer<br />

Craig; ophthalmologists Dr Simon Dean and Dr<br />

Shanu Subbiah; AUT’s Professor of Public Health<br />

Grant Schofield; and TedXAuckland speaker and<br />

ophthalmic registrar Dr Hong Sheng Chiong.<br />

The major sponsors of Snowvision this year<br />

include Ophthalmic Instrument Company, Hoya<br />

for the opening cocktail function, Corneal Lens<br />

Corporation for the BBQ lunch at Coronet Peak,<br />

Independent Lens Specialists for the golf and<br />

CR Surfacing for the Go-Karting championship.<br />

All the <strong>2016</strong> sponsors have a long history of<br />

supporting the Snowvision event.<br />

The conference will be offering discounted<br />

accommodation rates at the Crowne Plaza<br />

Hotel and plenty of rooms have been secured<br />

for delegates to book when registrations open<br />

through the website.<br />

Registrations open mid-April and can be<br />

done online at www.registerhere.co.nz/snow.<br />

If you are a previous delegate of Snowvision a<br />

broadcast email will be sent to you advising when<br />

registrations are open. If you would like to be<br />

added to this list please email snowvision<strong>2016</strong>@<br />

xtra.co.nz with your name, practice name and<br />

email address. Snowvision is open to optometrists<br />

and ophthalmologists.<br />

Once a registration is submitted delegates have<br />

two weeks to submit payment otherwise the<br />

registration becomes invalid. Early registration<br />

for the event is critical to be guaranteed a place<br />

and will be allocated on a first-come, first-served<br />

basis. ▀<br />

Bocca/Alium<br />

boost sales<br />

Face à Face sales boosted by Bocca and Alium<br />

A<br />

year after the integration with the Pro<br />

Design International group, Pascal Jaulent<br />

and Nadine Roth are celebrating the 20th<br />

anniversary of their common entity, Architectures,<br />

the mother company of Face à Face and WOOW and<br />

their extensions, Alium and Bocca.<br />

The company announced that 2015 closed with<br />

two-digit growth in sales, driven by the Face à<br />

Face brand, which successfully launched its Bocca<br />

range in 2013. Though first launched as a capsule<br />

collection, today Bocca has come into its own,<br />

accounting for more than 25% of Face à Face sales.<br />

In the announcement, the company said Bocca’s<br />

identity so strong, “it has captured the preference<br />

of many women who fell in love with the über<br />

feminine, sensual style, which is colourful and<br />

playful at the same time.”<br />

Face à Face’s Alium range, meanwhile, offers a<br />

very male style, and now represents nearly 20% of<br />

Face à Face sales. Alium is the best demonstration<br />

that innovation in the high range segment can<br />

be translated into commercial success, said the<br />

company.<br />

WOOW, meanwhile, has turned into the not-solittle<br />

“little brother” of the brand family. Launched<br />

two years ago, WOOW aimed to answer the strong<br />

demand for more accessible, but distinctively<br />

stylish products. The last Silmo collection built on<br />

the success of previous ones to develop more new<br />

models and boost the sunglasses range.<br />

Face á Face and WOOW are distributed by Eyes<br />

Right Optical through Mike Sladen Optical in<br />

New Zealand. ▀<br />

Education Series <strong>2016</strong><br />

Seminars<br />

are FREE!<br />


Tuesday 24th May <strong>2016</strong><br />

6.30pm - 8.45pm<br />

Theme:<br />

Diagnostics and<br />

Therapeutics in<br />

Everyday Practice<br />

Venue:<br />

Ellerslie Event Centre<br />

Racecourse, 80 Ascot Ave<br />

Ellerslie, Auckland<br />

Registration:<br />

5.45pm - 6.30pm<br />

Light Meal & Beverages<br />

provided<br />

Eye Institute’s Education Series continues to offer an opportunity for the Optometry Profession to gain exposure<br />

to the latest advances in therapeutics, shared-care management and surgical advances in New Zealand.<br />

You are invited to join us on one or more of the following Seminars and Conferences for the <strong>2016</strong> year.<br />

2nd Seminar<br />

Tuesday 16th August<br />

6.30pm - 8.45pm<br />

Ellerslie Event Centre<br />

Racecourse, 80 Ascot Ave<br />

Ellerslie, Auckland<br />


BOOK NOW!<br />

for your <strong>2016</strong> CPD Credits<br />

(including Therapeutics)<br />

Optometry Conference<br />

Sunday 6th November<br />

8am - 5pm<br />

Waipuna Hotel & Conference<br />

Centre, 58 Waipuna Road,<br />

Mt Wellington, Auckland<br />

PLUS 1/2 day workshops<br />

Saturday PM 5th November<br />

www.eyeinstitute.co.nz/optometry<br />

Or register by contacting...<br />

Tracy Richmond<br />

Ph 09 522 2125 | Fax 09 522 5770<br />

conference@eyeinstitute.co.nz<br />

Dispensing Optician Conference<br />

Sunday 6th November<br />

8am - 5pm<br />

Waipuna Hotel & Conference<br />

Centre, 58 Waipuna Road,<br />

Mt Wellington, Auckland<br />

<strong>Mar</strong>ch <strong>2016</strong><br />



SPECIAL FEATURE: CCLS Conference<br />

CCLS plans fantastic event<br />



WELLINGTON <strong>2016</strong><br />



Prof Fiona Stapleton, University of NSW<br />





Conference and workshop registration opens December 2015.<br />

For more information visit www.contactlens.org.nz<br />



Run by Wellington ophthalmologists<br />

Jesse Gale, Graham Reeves, with contributions<br />

from Prof Tony Wells and Dr Chris Murphy<br />




of New Zealand Incorporated<br />

It’s <strong>Mar</strong>ch, and that means one thing: the Cornea<br />

and Contact Lens Society is holding its one-day<br />

conference in Wellington.<br />

The site of the conference is the Mac’s<br />

Events Centre on the picturesque waterfront,<br />

centrally-located within walking distance of<br />

accommodations, Cuba Street and Te Papa Museum.<br />

The information-packed event features more<br />

than a dozen presentations by CCLS New Zealand<br />

member optometrists and ophthalmologists and<br />

some special guest speakers.<br />

“I think that we’re probably the only people who<br />

are pushing the contact lens barrow continuously”<br />

says Anne Matheson, CCLS president. “If you’re<br />

going to a general optometry conference, say, or a<br />

conference focusing on therapeutics, contact lenses<br />

might not be covered. We’re not monopolising the<br />

area, but we’re specialising on anything you want to<br />

know about contact lenses. We have that balance of<br />

optometrists and ophthalmologists.”<br />

Lower Hutt optometrist Greg Nel will give a<br />

presentation titled Setting up myopia control in<br />

a busy practice and Auckland optometrist Varny<br />

Ganesalingham will give a talk on setting up IPL.<br />

There will be updates on corneal cross-linking,<br />

public hospital referrals for cataract surgery and<br />

lid wiper epitheliopathy.<br />

Wellington ophthalmologist Dr Reece Hall will give<br />

a presentation about the Wellington Keratoconus<br />

Study, an ongoing research project that aims<br />

to determine the prevalence of Keratoconus in<br />

secondary school-aged students in years 9 and<br />

11, and said to be the first prospective study of<br />

Keratoconus in school children in the world.<br />

Special guests include Tony Alexander, chief<br />

economist for BNZ, who will provide an outlook for<br />

the New Zealand economy.<br />

“He talked at the RANZCO conference last year<br />

and some of the doctors who saw him said that<br />

was the best presentation they’d seen ever,” says<br />

Matheson.<br />

The keynote speaker, Professor Fiona Stapleton<br />

from the University of New South Wales, will give<br />

talks on the management of contact lens-related<br />

corneal infection; complications of the eyelids and<br />

CCLS president Anne Matheson<br />

Mac’s Event Centre<br />

the effects of contact lens; the impact of daily<br />

disposable contact lenses on corneal infection;<br />

and inflammation and dry eye (see separate Q&A<br />

with Stapleton).<br />

Bonus Glaucoma Workshop<br />

A big bonus this year is the one day Glaucoma<br />

workshop, held at The Meeting Space at 148 Cuba<br />

St on <strong>Mar</strong>ch 19. Organised as a benefit to CCLS<br />

members, the glaucoma workshop’s objective is<br />

to promote safe collaborative care in glaucoma<br />

treatment (see associated story).<br />

Why attend CCLS <strong>2016</strong>?<br />

Not only will the <strong>Mar</strong>ch 20 conference be an<br />

informative and lively day of presentations, but<br />

a weekend in Wellington offers a lot of fun and<br />

attractions when you’re not busy learning.<br />

The month-long Wellington Festival of the Arts<br />

wraps-up the same weekend, with options for<br />

comedy, theatre and visual arts (check out http://<br />

www.festival.co.nz/<strong>2016</strong>/festival-information/ to<br />

see what’s going on). There are also the Gallipoli<br />

exhibitions at Te Papa and The National War<br />

Memorial, the Zealandia wildlife sanctuary and<br />

much more.<br />

For Matheson, there is also the chance to<br />

support an organisation that brings together<br />

great expertise every year, from home and abroad,<br />

focused on contact lenses and the corneal surface.<br />

“This is not a money making venture. We do<br />

this for our members and they should turn up to<br />

learn, to support their colleagues and to widen<br />

their scope. Our meetings have a different flavour<br />

to others.” Matheson says non-members are very<br />

welcome to attend, as well.<br />

Registration opens at 7.30 am on <strong>Mar</strong>ch 20<br />

and breakfast will be served at 8 am, with the<br />

president’s welcome at 8.28 am. Lectures begin<br />

at 8.30 am, lunch at 12.30 pm, and the AGM at<br />

1.30 pm with lectures restarting at 2.10 pm. The<br />

educational day finishes at 5 pm when you’ll be<br />

rewarded with cocktail hour.<br />

For more and to register visit: http://www.<br />

contactlens.org.nz/in-focus/upcoming-events/ ▀<br />


Alcon Australia has launched Systane Hydration Lubricant Eye<br />

Drops, a unique* dual polymer formula containing hydroxypropyl<br />

guar (HP-guar) and hyaluronic acid (HA) which acts as a ‘bandage’<br />

to allow restoration of the damaged ocular surface.*<br />

The combination of HP-Guar and hyaluronic acid as the sodium<br />

salt (a naturally occurring compound of the body) attaches to<br />

cells on the corneal epithelium and entraps water for prolonged<br />

protection and greater hydration than hyaluronic acid alone.*<br />

Systane Hydration Lubricant Eye Drops can be used for dry eye<br />

patients who need increased hydration and lubrication that allows<br />

for restoration of the ocular surface.<br />

This new addition to the Alcon Systane brand is available as a<br />

multi-dose bottle and a preservative-free unit dose. ▀<br />

* References available from Alcon Laboratories (Australia).<br />

E>EYE<br />

More than 80% of patients who received E>Eye<br />

intense pulsed light (IPL) treatments in a<br />

recent study reported their dry eye symptoms<br />

had improved, while 95.7% said they would<br />

recommend the treatment to others.<br />

The results were part of a survey of E>Eye<br />

patients at Merivale Optical who were<br />

treated over a 10-month period. Of the 86<br />

respondents, 74.4% were over 60, 23.3% were<br />

between 20 and 40 and 2.3% were between<br />

20 and 40. The research was conducted by<br />

John Veale, optometrist at Merivale and NZ<br />

distributor for France Medical’s E>Eye machine.<br />

The E>Eye machine has been specifically<br />

designed for treating dry eye due to<br />

meibomian gland dysfunction (MGD). The<br />

device works by producing a calibrated series<br />

of IPL. These light pulses are precisely set at a<br />

specific energy and frequency to stimulate the<br />

meibomian glands and help them to recover<br />

their function.<br />

For more information about the E>Eye<br />

machine, come visit us at the E>Eye stand at<br />

the CCLS conference in Wellington. ▀<br />

Complete Dry Eye<br />

Analysis<br />

Diagnostic Dry Eye Assessment<br />

Meibo-scan<br />

• Infra Red LED<br />

Imaging<br />

• Blue & White LED<br />

TF-Scan<br />

• White LED<br />

TF-Scan, R-scan<br />

• White or IR Placido-ring<br />

NEW JENVIS Dry Eye Report<br />

Brings together results of the Dry Eye Questionnaire, Lid<br />

parallel conjunctival folds slit lamp examination and four<br />

measures with the Keratograph, summarising the results<br />

in an easy to understand, graphical format for the patient<br />

and eye care provider.<br />

Current price<br />

available until<br />

October 1<br />

Achieving<br />

great results<br />

throughout<br />

NZ<br />

I started using E►Eye in January 2014. It quickly became evident that patients<br />

were extremely happy with the results. In particular, the patients with obvious<br />

rosacea were describing huge improvements in their ocular comfort and an<br />

improvement in their conjunctival injection. For a condition that previously had<br />

limited therapeutic options, IPL is an exciting and highly effective new treatment<br />

modality for patients with dry eye from MGD.<br />

Dr Brendan Cronin, Ophthalmologist<br />

I invested in E►Eye with peace of mind as I would have got my money back<br />

in the first three months if it was not successful.<br />

Not only my dry eye patients were happy with their IPL treatments but they<br />

also recommended their friends and relatives to get treated too and this has<br />

become a very profitable service for my business. In fact, in less than four<br />

months, I had already got the return on my investment!<br />

There is no other optometry equipment on the market with such a quick<br />

return and it definitely makes my practice stand out from the crowd. E►Eye is<br />

definitely the best piece of equipment that I have invested in.<br />

It is attracting on average three to five new customers per week and these<br />

customers are now coming to buy our frames and have their eyes examined.<br />

John Veale, Optometrist<br />

Freecall: 0800 338 800<br />

www.designsforvision.co.nz<br />

A division of Paragon Care Group of Companies<br />

For more information visit our website<br />

www.dryeyesyndrome.co.nz<br />

or email us info@dryeyetreatment.co.nz<br />

My eyes felt great after three treatments and continue to improve in regards<br />

to tolerance of air conditioning and computer use, especially after a long day.<br />

Thank you for being so kind and allowing me to have the treatment. My eyes felt<br />

so much better I was finally encouraged to apply for a job and was successful.<br />

Sofia, dry eye sufferer from Sydney<br />

10 NEW ZEALAND OPTICS <strong>Mar</strong>ch <strong>2016</strong>




The SYSTANE ® portfolio Protects, Preserves and<br />

Promotes a Healthy Ocular Surface 1–5 . See eye care<br />

through a different lens with our innovative portfolio.<br />

Surface protection and more<br />


References: 1. Christensen M, Blackie CA, Korb DR, et al. An evaluation of the performance of a novel lubricant eye drop. Poster D692 presented at: The Association for Research<br />

in Vision and Ophthalmology Annual Meeting; May 2-6, 2010; Fort Lauderdale, FL. 2. Christensen, M, <strong>Mar</strong>tin, A, Meadows, D. An Evaluation of the Efficacy and Patient Acceptance of a New<br />

Lubricant Eye Gel. Presented at American Academy of Optometry 2011, Boston, MA. 3. Davitt WF, Bloomenstein M, Christensen M, et al. Efficacy in patients with dry eye after treatment<br />

with a new lubricant eye drop formulation. J Ocul Pharmacol Ther. 2010;26(4):347-353. 4. Aguilar A. Efficacy of a Novel Lubricant Eye Drops in Reducing Squamous Metaplasia in Dry Eye<br />

Subjects. Presented at the 29th Pan-American Congress of Ophthalmology in Buenos Aires, Argentina, July 7-9, 2011. 5. Geerling G, et al. The International Workshop on Meibomian<br />

Gland Dysfunction: Report of the Subcommittee on Management and Treatment of Meibomian Gland Dysfunction. IOVS. 2011;52(4):2050-2064. Alcon Laboratories (Australia)<br />

Pty Ltd. 10/25 Frenchs Forest Road East, Frenchs Forest NSW 2086. Distributed by Pharmaco (NZ) Ltd in New Zealand, 4 Fisher Crescent, Mt. Wellington , Auckland. Ph 0800 101 106.<br />

POPH.15104. TAPS.PP6717. NP4.A21507352604.<br />

<strong>Mar</strong>ch <strong>2016</strong><br />



SPECIAL FEATURE: CCLS Conference<br />

Q&A with Fiona Stapleton<br />



WELLINGTON <strong>2016</strong><br />





Prof Fiona Stapleton, University of NSW Run by Wellington ophthalmologists<br />

Jesse Gale, Graham Reeves, with contributions<br />


from Prof Tony Wells and Dr Chris Murphy<br />


What’s<br />





Conference and workshop registration opens December 2015.<br />

For more information visit www.contactlens.org.nz<br />


of New Zealand Incorporated<br />

This year’s keynote speaker, Fiona<br />

Stapleton, is professor and head of the<br />

School of Optometry and Vision Science<br />

at the University of New South Wales in<br />

Sydney. She graduated in Optometry from the<br />

University of Cardiff, Wales and was awarded<br />

her PhD from City University and Moorfields<br />

Eye Hospital in London. Her research areas<br />

include the epidemiology of lens-related<br />

disease, ocular microbiology, bacterial<br />

resistance, contact lens care systems and<br />

ocular defense mechanisms. She has authored<br />

more than 160 peer-reviewed publications and<br />

a book on the diagnosis and management of<br />

anterior segment disease.<br />

How often do you get to New Zealand?<br />

It has been a while. The last time I was over, it<br />

was for CCLS in Auckland. This will be my first visit<br />

to Wellington and I’m really looking forward to<br />

spending a few days looking around. The national<br />

museum looks amazing.<br />

What’s your personal motivation for doing<br />

conference lectures?<br />

I’m really fortunate in my job. I’m passionate about<br />

making contact lens wear safer and more accessible<br />

and that has driven much of my research. Speaking<br />

to practitioners at conferences is a two-way street:<br />

it gives me the chance to share what I have been<br />

working on, which I hope is of some interest and<br />

relevance to practice, and I learn so much from<br />

speaking with practitioners about their experiences.<br />

You’ve published a lot about infections<br />

and contact lenses; what is your current<br />

area of research?<br />

I’m still working on corneal infections, but not<br />

just in contact lens wear. I’m interested in it from<br />

the perspective of understanding risk-factors and<br />

wearer-behaviour, characteristics of the organisms<br />

causing disease and host genetic factors, all of<br />

which can influence developing the condition and<br />

the severity of the infection. I have come to believe<br />

that among contact lens wearers there will always<br />

be a baseline risk of getting a corneal infection, but<br />

what we might be able to influence is the disease<br />

severity, so reducing the duration, the likelihood of<br />

vision loss and the cost to treat.<br />

I’m also very interested in how we can solve<br />

contact lens related discomfort, particularly with<br />

understanding tear film changes and changes to<br />

the lipid layer of the tear film. I think a major area<br />

of research in my future will be in contact lens wear<br />

in children, with contact lens options for myopia<br />

control particularly and specifically understanding<br />

the impact of lens wear in children.<br />

What do you hope attendees will take<br />

away from your presentations at CCLS?<br />

I have a couple of presentations on corneal<br />

infections in contact lens wear. These focus on<br />

reducing the risk of disease, strategies for limiting<br />

disease severity and treatment. While daily<br />

disposable contact lenses have the same rate of<br />

infection as frequent replacement contact lenses,<br />

the risk of severe disease is reduced and infections<br />

are less likely to be caused by environmental<br />

organisms. We are also beginning to understand<br />

the impact of immune status and individual<br />

differences in disease susceptibility. In frequent<br />

replacement users, we now know the importance<br />

of what wearers do with their storage cases in<br />

preventing infection. There is a large body of work<br />

showing the importance of avoiding water in lens<br />

handling and I hope that drawing together some<br />

of this recent work will provide some relevant tips<br />

for practitioners and their patients.<br />

My other presentations cover complications of<br />

the eyelids and an update on the epidemiology<br />

of dry eye. Both of these will focus on who is<br />

predominantly affected, what remains unknown<br />

and new learnings which might assist in our<br />

management of these conditions<br />

Do you foresee a time when contact<br />

lenses for presbyopia might be replaced<br />

by hydrogel inlays, eye-drop treatments or<br />

other new developments?<br />

I think there are some really interesting research<br />

avenues in these areas, but we do seem to be<br />

some way off from commercial reality. Lens wear<br />

is reversible: power and optics can be modified.<br />

Surgical options - less easily so. I think we need to<br />

maintain our efforts to retain wearers in lens wear<br />

as they become presbyopic, needing well-designed<br />

comfortable lenses, in a daily disposable modality.<br />

Considering the poor habits of many<br />

contact lens wearers, is there any possibility<br />

of eliminating infection through material<br />

science or improved lens care systems?<br />

new:<br />

glaucoma<br />

workshop<br />

The <strong>Mar</strong>ch 19 Glaucoma Workshop, organised<br />

as part of the <strong>2016</strong> CCLS conference in<br />

Wellington, adds more potential for learning<br />

than ever before, say organisers.<br />

The workshop’s objective is to promote safe<br />

collaborative care in glaucoma, centred on<br />

interactive discussions based on clinical cases.<br />

The aim is to highlight evidence-based decision<br />

making, recognising dangerous situations and<br />

some concepts and models relevant to managing<br />

glaucoma in a population.<br />

The main speakers will be ophthalmologists Dr<br />

Jesse Gale of Wellington and Dr Graham Reeves of<br />

Auckland, as well as contributions from Wellington<br />

School of Medicine Professor Tony Wells and<br />

Waikato ophthalmologist Dr Chris Murphy.<br />

“The key concept we want to explore is the idea<br />

of collaborative care in glaucoma management,”<br />

says Gale. “That has been a controversial<br />

topic, especially in Australia, but it’s the future<br />

and I think it’s the position of the College of<br />

Ophthalmologists that collaborative care is the<br />

healthy way to look after the patient.”<br />

“That means sharing the uncertainty and sharing<br />

the risk when you’re unsure what will happen and<br />

you can’t predict the future. This can be done in<br />

unintelligent and wasteful ways that waste money<br />

and time and there are ways that it can be done<br />

efficiently and we want to talk about ways people<br />

have tried collaborative care.”<br />

Distributed by:<br />

phone: 09 443 0072<br />

email: tim@oic.co.nz<br />

I do have some sympathy for contact lens wearers,<br />

with respect to their wear and care habits. As<br />

an example, we did a study a couple years ago<br />

surveying contact lens practitioners about what<br />

they advised their wearers to do in the area of<br />

case hygiene. I reckon with 100 practitioners<br />

we must have had 200 different opinions about<br />

what wearers should do. It’s sometimes not clear<br />

what best practice is so, in some respects, it is not<br />

surprising there are difficulties with compliance.<br />

Material science is interesting, certainly in the<br />

comparison of silicone hydrogel and hydrogel<br />

lenses, rates of infection are not appreciably<br />

different although rates of corneal infiltrates are.<br />

My feeling is that we will have a baseline risk which<br />

may not be reduced with different materials or<br />

lens care systems. In terms of lens care systems,<br />

some are better than others with respect to the<br />

risk of infection and we may see an incremental<br />

improvement with new technologies, but we have a<br />

residual risk of infection in the absence of solutions<br />

in the daily disposable model.<br />

I’m very much looking forward to coming over<br />

and thank you for the opportunity to share some<br />

thoughts. ▀<br />

CLC<br />

Corneal Lens Corporation is a leading developer<br />

of contact lenses and eye products in New<br />

Zealand. We are excited to announce the<br />

arrival of the new Menicon Signature Pack,<br />

containing 4x Menicare Soft Solution and<br />

2x Miru Monthly Disposable Lenses. This<br />

Signature Pack is competitively priced and is<br />

the only pack on the market that contains both<br />

disposable lenses and solution.<br />

Macushield is the only nutritional supplement<br />

that contains Lutein, Zeaxanthin and Meso-<br />

Zeaxanthin. These ingredients, especially<br />

Meso-Zeaxanthin, help convert Lutein to the<br />

macular, preventing AMD. Recent studies have<br />

shown a direct correlation between AMD and<br />

Alzheimer’s, therefore it is essential for the<br />

elderly population to have Meso-Zeaxanthin to<br />

combat AMD and, in-turn, Alzheimer’s.<br />

Plus a revolution in Scleral lens fitting has<br />

come to New Zealand. Come and see the sales<br />

team from CLC at the CCLS Conference and ask<br />

about S Map 3D. ▀<br />

Dr Jesse Gale will lead the workshop<br />

Gale is a general ophthalmologist and cataract<br />

surgeon, with subspecialty training in glaucoma<br />

and neuro-ophthalmology. Gale is developing<br />

collaborative new research projects in Wellington<br />

into how glaucoma and other optic nerve<br />

problems are linked and differentiated. He has<br />

an interest in managing eye diseases across<br />

populations, exploring new online systems<br />

for enhancing collaborative care between<br />

optometrists and ophthalmologists to improve<br />

patient pathways and to reduce unnecessary<br />

testing and travel.<br />

“The potential advantage (of collaborative<br />

care) to the patient is it may be easier to see an<br />

optometrist than an ophthalmologist,” says Gale.<br />

“You can see one closer to home and virtually any<br />

time you want. But it’s difficult to get a referral<br />

and get access to ophthalmologists.”<br />

Gale says collaborative care models have been<br />

rolled out in the UK, particularly as a way to<br />

reduce costs and burden on the public hospital<br />

system, and there is evidence emerging that<br />

collaborative care accomplishes these goals.<br />

New Zealand already has a tradition of a<br />

cooperation among ophthalmologists and<br />

optometrists, says Gale, which makes for a good<br />

foundation to adopt a collaborative approach to<br />

glaucoma management here.<br />

The workshop begins at 9 am and finishes at<br />

4 pm. The Meeting Space is on level 2 of 148 Cuba<br />

Street and is adjacent to Capital Eye Specialists<br />

consulting rooms. The entrance to the building is<br />

on Garrett Street. ▀<br />

12 NEW ZEALAND OPTICS <strong>Mar</strong>ch <strong>2016</strong>

COMPLETE RevitaLens®<br />

Contact lens cleaning solution for<br />

soothing protection and lasting comfort.<br />



fOR yOuR<br />

With OcuTec ®<br />

dual disinfection action<br />

for superior clean and<br />

NON-COMPLIANT PATIENTs 1 all day comfort.<br />



ALWAYS READ THE LABEL, USE ONLY AS DIRECTED. References: 1. Powell H, Hoong L, Kilvington S, Lam A, Lonnen J. Evaporation effects on the efficacy of contact lens multipurpose solutions. Poster presented at: British Contact Lens Association’s 34th Clinical Conference and Exhibition; May 27-30, 2010; Birmingham,<br />

UK. 2. Data on file – 131, 2011. Abbott Medical Optics Inc. Santa Ana, CA. Global multi-site clinical assessment of RevitaLens OcuTec MPDS. Abbott Medical Optics – Australia: Abbott Medical Optics 299 Lane Cove Road, Macquarie Park, NSW 2113, Australia. Phone: 1800 266 111. New Zealand: Abbott Medical Optics (AMO<br />

Australia Pty Ltd) PO Box 401, Shortland Street, Auckland, 1140. Phone: 0800 266 700. © <strong>2016</strong> Abbott Medical Optics Inc. COMPLETE RevitaLens, OcuTec and the COMPLETE logo are trademarks owned by or licensed to Abbott Laboratories, its subsidiaries or affiliates.<br />

<strong>Mar</strong>ch<br />

PP2015CN0184<br />

<strong>2016</strong> NEW<br />

TAPS PP7485<br />


WH AMO<strong>2016</strong>5_NZO<br />

OPTICS<br />


SPECIAL FEATURE: CCLS Conference<br />



WELLINGTON <strong>2016</strong><br />



Never a dull<br />

moment<br />

Optometrist<br />

Reuben<br />

Gordon’s<br />

CCLS <strong>2016</strong><br />

presentation<br />

sounds anything<br />

but boring despite<br />

being entitled<br />

Boring cases in<br />

the hospital.<br />

“I work with<br />

one of the board<br />

members, Richard<br />

Johnson. When he<br />

approached me,<br />

he told me Eleisha<br />

(Dudson) was<br />

doing interesting<br />

Ruben Gordon<br />

cases so that<br />

leaves me with the boring ones, so the title was<br />

really a joke,” Gordon laughs.<br />

Gordon is an optometrist at the Greenlane Eye<br />

Clinic in Auckland and also works for Dr Shanu<br />

Subbiah at Eye Institute. His work with advanced<br />

keratconus and post corneal graph patients<br />

makes his life interesting and it’s those cases he<br />

will be discussing at the conference, he says.<br />

With the difficult shape of the cornea, the<br />

cases Gordon must deal with are often the<br />

most challenging. There is no one size fits all<br />

in keratconus and post corneal graph contact<br />

lens fitting, he says. “It’s about getting to know<br />

the different designs. It varies from person to<br />

person. But usually we can find something that<br />

can stay in place.”<br />

Gordon has been an optometrist since 2007.<br />

He says his favorite aspect of the job is the<br />

challenging cases and working closely with<br />

patients to get the best results. He says he hopes<br />

to impress upon his audience the idea that they<br />

can be more adventurous with what contact<br />

lenses they fit and to branch out into new<br />

designs. ▀<br />

Beyond the surface<br />

Experience is always a good teacher. For<br />

Eleisha Dudson, a member of the CCLS<br />

council and one of the <strong>2016</strong> conference<br />

presenters, her experience with a few different<br />

cases will be key as she takes the audience<br />

through Superficial issues: unusual cases—<br />

management and strategy.<br />

Dudson, a practising optometrist since 2007, is<br />

based with Stevenson, Sangster & Matthews<br />

in Wellington. She says she’s excited to be<br />

participating in this year’s CCLS conference.<br />

“I have a couple cases I want to go through that<br />

didn’t really start off as anterior issues, but as<br />

things progressed, that’s what they turned out to<br />

be.” But rather than being about “this is how you<br />

deal with that case,” Dudson says shes going to<br />

discuss how to approach things.<br />

Her interest is in specialty contact lens fitting,<br />

orthokeratology and the management of anterior<br />

eye conditions. She’s currently chair of the<br />

Wellington branch of the NZAO and joined CCLS<br />

in 2015.<br />

Not wanting to spoil it for attendees, Dudson<br />


Abbott Eye Health is pleased to be attending<br />

the CCLS conference this <strong>Mar</strong>ch in Wellington.<br />

Abbott will be launching COMPLETE Revitalens<br />

Multi-Purpose Disinfecting Solution (featured<br />

on the cover of February’s edition of NZ<br />

Optics). COMPLETE Revitalens MPDS has been<br />

incorporated under the COMPLETE banner with<br />

sample starter kits available for you to trial<br />

with your patients. Abbott will also showcase<br />

Blink Intensive Tears Plus Gel Drops for patients<br />

with severe dry eye. Blink Intensive Tears PLUS<br />

Gel Drops’ visco-elastic technology provides<br />

maximum lubrication with minimum blurring.<br />

Abbott representative, Rachel Haynes, will be<br />

on the stand at CCLS and will be happy to take<br />

any questions from you on the day. Rachel has<br />

been with Abbott Eye Health for four years and<br />

has a breadth of knowledge relating to contact<br />

lens and ocular surface care. We look forward to<br />

seeing you all in Wellington! ▀<br />

Eleisha Dudson<br />

didn’t want to go too deeply into details about<br />

the kind of cases she’d be discussing, but says<br />

she will draw from research, information from<br />

suppliers and websites about Ortho-k and other<br />

resources to help approach cases that are not so<br />

straightforward. ▀<br />


Device Technologies is proud to support<br />

the CCLS and is excited to welcome a<br />

new instrument to the Topcon NZ family,<br />

presented at CCLS Wellington for the first<br />

time, the Topcon CA-800 Topographer and<br />

Meibomian Gland viewer with network<br />

integration for smooth practice workflow.<br />

As always Topcon is offering time saving and<br />

ergonomic devices for every ophthalmic and<br />

optometric practice including: computerised<br />

phoropters, computerised lensmeters,<br />

4-in-1 autorefractors, abberometers,<br />

topographers, chair and stands, photo and<br />

video slit lamps, spectral domain OCT and,<br />

of course, our new swept source OCT – the<br />

Topcon Triton.<br />

We will also be exhibiting Captiv8, a patient<br />

communication and marketing service for<br />

iPad, PC, websites and waiting rooms. ▀<br />


Prof Fiona Stapleton, University of NSW<br />





DESIGNS Conference and workshop FOR registration opens VISION<br />

December 2015.<br />

For more information visit www.contactlens.org.nz<br />


Run by Wellington ophthalmologists<br />

Jesse Gale, Graham Reeves, with contributions<br />

from Prof Tony Wells and Dr Chris Murphy<br />



Oculus’ versatile Keratograph 5M has<br />

established itself as a comprehensive dry eye<br />

analysis tool (along with its core function of<br />

corneal topography) and now adds a new<br />

feature: the JENVIS Dry Eye Report.<br />

The JENVIS Dry Eye Report summarises<br />

the results of dry eye exams in an easy to<br />

understand, graphical format. The report can be<br />

stored in the PC and printed for the patient to<br />

keep as a record of their current dry eye status.<br />

The report brings together results of the Dry<br />

Eye Questionnaire (either McMonnies or OSDI<br />

type), lid-parallel conjunctival folds examination<br />

with slit lamp, plus four key measurements with<br />

the Keratograph: Tear Meniscus height, NIKBUT<br />

(non-invasive Keratograph break-up time),<br />

R-Scan (conjunctival redness score), and Meibo-<br />

Scan (meibography of the glands).<br />

Other metrics can also be added, such as<br />

corneal staining or lipid layer, and each of them<br />

is explained in plain language so the patient<br />

understands the result. The practitioner can also<br />

add suggested in-office or home therapies in a<br />

“recommendations” section.<br />

The JENVIS Dry Eye Report is included in the<br />

TF-Scan module of the Keratograph software.<br />

Older Keratograph 5M and Keratograph 4<br />

models can also be upgraded by purchasing<br />

the corresponding license. ▀<br />

CCLS <strong>2016</strong> EXHIBITORS<br />

Abbott Medical Optics<br />

Alcon<br />

Bausch + Lomb<br />

CooperVision<br />

Corneal Lens orporation<br />

Device Technologies<br />

Dry Eye Technology (E>Eye)<br />

Johnson & Johnson<br />

Ophthalmic Instrument Company<br />

OptiMed NZ<br />


of New Zealand Incorporated<br />



The World’s 1st commercially available<br />

posterior & anterior swept source OCT!!<br />

New Menicon<br />

Signature Pack<br />

Penetrates through cataracts<br />

& haemorrhages<br />

High Speed Scanning<br />

Wide-field OCT (12-9mm)<br />

NEW Combination Scan<br />

Anterior Segment<br />

3D Wide Scan + 5 Line Cross<br />

/ B-Scan in one capture<br />

Optional Fluorescein &<br />

Autofluorescence photography<br />

• Includes 2 x Miru Monthly and 4 x Menicare Soft 360ml<br />

• Money back guarantee (Conditions Apply)<br />

TRITON<br />

To order phone: 0800 954 536 or<br />

email: sales@corneal-lens.co.nz<br />

14 NEW ZEALAND OPTICS <strong>Mar</strong>ch <strong>2016</strong>

Reflections on the WOC<br />


The 35th World Ophthalmology Congress,<br />

together with the 32nd Pan American<br />

Ophthalmology Congress and the Mexico<br />

Ophthalmology Society, was held in the beautiful<br />

city of Guadalajara, the second largest city in Mexico<br />

from February 5 - 9. It attracted more than 7,000<br />

delegates from across the world.<br />

The breaking news from the congress was a report<br />

from Brazil on the linkage of optic nerve abnormality<br />

and macular scarring to the Zika virus epidemic. In<br />

addition, there were many updates in other areas of<br />

ophthalmology including the prevention of visual<br />

impairment in young children, especially against<br />

myopia and retinopathy of prematurity (ROP).<br />

I chaired the International Council of<br />

Ophthalmologists Invited Symposium on ROP,<br />

in which I spoke along with fellow Auckland<br />

ophthalmologist Dr Justin Mora. The ROP<br />

symposium was well-attended with more than 500<br />

ophthalmologists, all interested in discussing the<br />

call for urgent worldwide action to prevent ROPrelated<br />

visual impairment, with more than 30,000<br />

blinded annually.<br />

Other Kiwis who attended the congress included<br />

Dr Kenneth Chan, an ophthalmologist from<br />

Luxury, now<br />

with technology<br />

Centro Cultural Cabañas, one of the oldest hospital complexes in the Americas<br />

Wellington, and Dr Ilva Rupenthal, a vision scientist<br />

and director of the Buchanan Ocular Therapeutics<br />

Unit at the University of Auckland.<br />

Besides the many learnings gleaned during the<br />

congress, the richness of Mexico’s history and<br />

culture was illustrated at the Mexican Kermesse<br />

(cultural festival) which took place at Centro<br />

Cultural Cabañas, a World Heritage site, and one<br />

of the oldest and largest hospital complexes in the<br />

Americas. ▀<br />

WOC Kiwi presenters Drs Justin Mora and Shuan Dai<br />

* Dr Shuan Dai is a founding director of Eye Doctors and a<br />

consultant ophthalmologist at Greenlane Clinical Centre and<br />

Starship Children's Hospital in Auckland. He is a clinical senior<br />

lecturer at Auckland University; a member of the American<br />

Association of Paediatric Ophthalmology and Strabismus<br />

Surgeons and a visiting ophthalmologist for the Blind and Low<br />

Vision Educational Network.<br />

The new Zeffer line from Jono Hennessy<br />

Jonathan (Jono) Hennessy Sceats has launched a new brand of<br />

eyewear called Zeffer.<br />

Sceats knows a thing or two about eyewear, fashion and design,<br />

having been in the business for more than 35 years and he’s brought<br />

all these aspects together to create this new collection.<br />

Previewed at Silmo 2015, Zeffer is now available in New Zealand.<br />

<strong>Mar</strong>k Collman of Phoenix Eyewear, who distributes all of Jono<br />

Hennessy’s ranges in New Zealand, says since the “soft” launch<br />

late last year, Sceats advanced the Zeffer collection quite quickly<br />

and already has a large number of new styles in production and<br />

development for stages two and three.<br />

“Jono had been looking for the right factory for years to develop<br />

this collection with and he’s succeeded. He is so fussy, but in a<br />

good way. He insists on premium quality and I think you will agree<br />

these frames are amazing. Zeffer is a technology brand uniting<br />

cutting-edge materials, high density cellulose acetate (HDCA) and<br />

titanium. The HDCA material, used for the frame fronts, is super<br />

strong, super light and its flexibility means it can be milled down<br />

to 2 mm. The design is such that no nosepad is required.”<br />

Another technology feature is the high quality Apple-designed,<br />

OBE pentalobe starhead screws in some Zeffer frames which lock<br />

and don’t come loose, says Collman.<br />

Ball appointed<br />

to fix Alcon<br />



LIKE YOU<br />



Swiss pharmaceutical giant<br />

Novartis appointed former<br />

Hospira CEO Michael Ball<br />

to replace the head of its Alcon<br />

division, Jeff George, from February.<br />

Novartis is hoping Ball can<br />

transform Alcon like he transformed<br />

Hospira, before selling it to Pfizer for<br />

US$15 billion at the end of last year,<br />

netting himself US$90 million in the<br />

process.<br />

In announcing Ball’s appointment,<br />

Novartis said it'll transfer most of<br />

Alcon's prescription eye drugs to<br />

the pharma division, leaving Ball to Michael Ball heads Alcon<br />

focus on "core surgical and vision care business."<br />

But, reporting weaker than expected fourth quarter earnings,<br />

Novartis chief executive Joe Jimenez told news reporters he did not<br />

expect the overhaul of Alcon to be a "quick fix."<br />

"The specific growth plan on Alcon is that we're going to focus<br />

the business on that core surgical and cataract surgery business,"<br />

he said.<br />

00144_CrizalUV_CSPosterA1_NOV15_v2.indd 1<br />



www.seethefuture.co.nz<br />

25+<br />

E<br />

- S P F<br />


24/11/2015 10:37:30 AM<br />

NZ optics.indd 1<br />

<strong>Mar</strong>ch <strong>2016</strong><br />

2/15/<strong>2016</strong> 5:11:16 PM<br />



with<br />

Prof Charles McGhee<br />

& A/Prof Dipika Patel<br />

Series Editors<br />

Contemporary glaucoma drainage surgery<br />

Introduction<br />


The nomenclature for glaucoma surgery is confusing because it is not<br />

consistent. A better way to understand the variety and uses of the<br />

surgical drainage options is to read the history of each.<br />

Some usages of “drainage surgery” apply only to tubes, but others<br />

apply the term to include incisional procedures which increase<br />

outflow as opposed to procedures which reduce inflow (for instance<br />

cyclodestruction).<br />

It is amazing how many different types of glaucoma operations are<br />

available around the world. The standard drainage operations for<br />

adults in New Zealand are trabeculectomy and the Molteno tube.<br />

Add to this short list angle surgery for infants.q<br />

Canaloplasty has been practised for two decades and is popular in<br />

centres in Europe but lacks exponents in New Zealand.<br />

Practice patterns vary around the world, NZ surgeons tend to<br />

get trained in English speaking centres like London and follow the<br />

techniques and exhibit the attitudes that are traditional in those<br />

centres upon returning to NZ. Also, no surgeon would want to<br />

expand his or her surgical repertoire to include all the procedures<br />

because there are too many.<br />

We are so lucky to have Tony Molteno. Tony trained in South Africa<br />

and he engineered and developed his own glaucoma procedure<br />

which enjoys an enduring place in glaucoma<br />

treatment throughout the world. Where Tony<br />

was in his thinking 40 years ago is where<br />

contemporary glaucoma surgery is trending<br />

now.<br />

There are two terms that should be banned<br />

because they are persuasive usages and not<br />

descriptive: minimally invasive glaucoma<br />

surgery (MIGS) and non-penetrating glaucoma<br />

Fig 1. Professor<br />

Anthony Molteno<br />

16 NEW ZEALAND OPTICS <strong>Mar</strong>ch <strong>2016</strong><br />

surgery. How minimal is minimally invasive?<br />

Lots of different operations could qualify. “Nonpenetrating”<br />

is used to link viscocanalostomy and<br />

deep sclerectomy but the term could be applied<br />

across other categories that are simply not the same.<br />

A final introductory comment with regard to the terms Ab Interno<br />

and Ab Externo. All incisional operations access the target tissue<br />

from the outside of the body. It is possible to operate on the angle<br />

structures using instruments positioned in the anterior chamber—<br />

this is what is meant by Ab interno. The anterior chamber is accessed<br />

directly through the peripheral cornea.<br />

Full-thickness drainage drocedures<br />

Trabeculectomy—Ab Externo<br />

Fig 2. Pseudophakia with diffuse lightly<br />

vascularised bleb and Express<br />

Trabeculectomy is<br />

achieved by making a<br />

hole in the wall of the<br />

eye at the limbus which<br />

permits the aqueous<br />

to drain from the<br />

anterior chamber thus<br />

lowering the IOP. The<br />

hole is more properly<br />

called a fistula. This<br />

opening is covered<br />

by flap of sclera so<br />

that the jet of exiting<br />

aqueous is diffused and does not come into contact with the<br />

conjunctiva directly to prevent the conjunctiva thinning, which is<br />

what happens if the conjunctiva is subjected to an aqueous jet. The<br />

modification of hiding the fistula under a partial thickness scleral<br />

flap has been in use since the late 1960s and is attributed to John<br />

Cairns (UK). The partial thickness scleral flap permits control over<br />

the rate of drainage and prevents hypotony, usually. The aqueous<br />

lifts up a blister of conjunctiva called the bleb. The body heals fistulae<br />

and it is remarkable that trabeculectomy is successful. However<br />

trabeculectomy failure can often be attributed to scarring of the bleb.<br />

Usage of antimetabolites can eliminate failure due to scarring but<br />

these have their own set of challenges.<br />

The challenges of using mitomicin in glaucoma surgery include<br />

causing avascularity, increasing infection risk and hypotony. Ologen<br />

is a collagen implant designed to modify tissue repair and avoid<br />

scarring. It been shown to have similar results to mitomicin for<br />

improving trabeculectomy outcomes and offers the advantage of<br />

avoiding mitomicin. Ologen is available for use—it works, but studies<br />

to five years show no difference in complication rates to mitomicin<br />

and mitomicin is cheap. 8<br />

Fig 3. Angle view of Alcon Express<br />

Fig 4. The Alcon Express<br />

Recent advances in trabeculectomy surgery include the use of stents<br />

to maintain the patency of the opening. The Alcon Express stent<br />

is available for this purpose. Instead of using a punch to make the<br />

opening, a needle is introduced into the anterior chamber. The Express is<br />

introduced along the route of the needle tract. This stent stays in the eye<br />

permanently. The advantages are increased control and less dissection.<br />

The size of the drainage fistula is the same every time, peripheral<br />

iridotomy is unnecessary, and a number of problems that beset standard<br />

trabeculectomy in the first weeks are avoided. Return of visual acuity is<br />

faster after Express. Medicare data from the US puts Alcon Express usage<br />

at half of all medicare trabeculectomy surgery. The Innfocus micro shunt<br />

is a plastic stent which requires less dissection than the Alcon Express<br />

(no scleral flap) and is seeking FDA approval this year.<br />

Trabeculectomy—Ab Interno.<br />

The Xen gel implant is a method of creating the trabeculectomy<br />

from within the anterior chamber. Xen is a collagen stent that<br />

was developed by AqueSys, Inc (acquired by Allergan in 2015). The<br />

Xen implant is inserted through the trabecular meshwork into the<br />

sub conjunctival space by an ab-interno approach. This method of<br />

achieving trabeculectomy avoids operating on the conjunctiva.<br />

Tubes with remote absorption surfaces (Molteno, Baerveldt &<br />

Ahmed)<br />

Drainage tubes innovated by Professor Tony Molteno were once<br />

kept for cases where trabeculectomy surgery had failed and other<br />

situations in which there is a high risk of trabeculectomy failure.<br />

However tubes are now used as a first line surgical option. The<br />

Trabeculectomy versus Tube study has led this change in practice:<br />

Five year results demonstrated similar efficacy in pressure lowering<br />

but a higher success rate and reduced re-operation rate in the tube<br />

group. 5 Medicare data from the USA shows the steady increase from<br />

2400 tubes in 2003 to 14,000 tubes in 2012. 2<br />

Partial-thickness drainage procedures<br />

Goniotomy is an Ab Interno procedure that opens Schlemm’s canal<br />

to the anterior chamber by incising the trabecular meshwork<br />

allowing aqueous direct access to Schlemm’s canal and the collector<br />

channels. A gonioprism provides a view of the angle through the<br />

operating microscope. The slender gonioknife enters the eye through<br />

a corneal wound and is passed across the anterior chamber to the<br />

trabecular meshwork opposite the corneal entrance wound and<br />

moved to slice along the trabecular meshwork for several clock<br />

hours of its circumference. The procedure was first described by<br />

Carlo De Vincentiis, a genial Neopolitan ophthalmic surgeon 1893.<br />

The approach is built on the assumption that elevation in IOP is<br />

due to increased resistance to outflow of aqueous at the trabecular<br />

meshwork. De Vincentis did not have a gonio prism and because of<br />

the poor success rates he achieved the procedure did not enter usage.<br />

However the method was picked up in the 1930s by Otto Barkan,<br />

who could visualise the angle. He found it to be extremely successful<br />

in congenital glaucomas and it remains the standard treatment.<br />

Trabeculotomy is the name given to the<br />

Ab Externo way of doing a goniotomy.<br />

Trabeculotomy is chosen if the cornea is too<br />

cloudy to permit gonioscopy. Schlemm’s canal<br />

is entered by incising down directly through<br />

the overlying sclera and introducing a fine<br />

curved rod called a Harm’s trabeculotome into<br />

a sector of the Schlemm’s canal and turning the<br />

handle so that the trabeculotome bursts into<br />

the anterior chamber through the trabecular<br />

meshwork. Goniotomy and trabeculotomy<br />

Fig 5. Carlo<br />

produce similar published outcomes.<br />

De Vincentiis,<br />

Interestingly a surprisingly large number of<br />

Neapolitan<br />

studies have addressed the usefulness of<br />

Ophthalmologist, trabeculotomy in adult glaucoma and reported<br />

1849 – 1904<br />

favourably. As an example a paper from 1993<br />

randomises 97 patients with POAG to either<br />

MMC trabeculectomy or trabeculotomy: the probability of successful<br />

IOP lowering at 12 months was the same but there were significantly<br />

more complications in the MMC trabeculectomy group. 3<br />

The contemporary adult<br />

goniotomy procedure is the<br />

Glauckos iStent. The iStent is<br />

inserted at the time of cataract<br />

surgery into the Schlemm’s canal<br />

and remains there permanently.<br />

It has a snorkel with a lumen<br />

into the aqueous which permits<br />

Fig 6. iStent by Glauckos, Inc passage of aqueous into the<br />

Schlemm’s canal. The iStent got FDA<br />

approval in 2013 and is available for purchase and use in NZ. It is<br />

also available for use in the public hospital in Auckland. Since the<br />

2012 multi-centre RCT that was accepted by the FDA 4 , many papers<br />

including meta-analyses have been published supporting the<br />

efficacy and safety of the iStent technique. 6<br />

The Ivantis Hydrus is a<br />

competing adult goniotomy<br />

technology which is not FDA<br />

approved but which is CE<br />

marked and can be used in<br />

Fig 7. Hydrus (Ivantis, inc)<br />

NZ. I am pleased to be trialling<br />

the Hydrus at Ascot Hospital. The Hydrus a malleable Nitinol alloy<br />

product which is introduced into the Schlemm’s canal usually<br />

at the time of cataract surgery. It scaffolds the Schlemm’s canal<br />

and connects it to the aqueous by it’s opening which remains<br />

permanently in the aqueous at the angle. 7<br />

Both Hydrus and iStent can be<br />

used in patients who are phakic or<br />

pseudophakic so long as there is space.<br />

Patients have valuable reductions<br />

in IOP with these new goniotomy<br />

technologies but most importantly<br />

Fig 8. Hydrus positioned<br />

within Schlemm’s canal with<br />

inlet in AC<br />

the complication rate is minimal<br />

especially when compared to standard<br />

trabeculectomy, the visual recovery<br />

is quick - hours compared to months<br />

for trabeculectomy and post op care<br />

is the same as cataract surgery. I have avoided using standard<br />

trabeculectomy by using these technologies in several patients.<br />

Miscellaneous<br />

Cyclodialysis<br />

Suprachoroidal clefts are little openings between the anterior<br />

chamber and the suprachoroidal space that occur with blunt trauma<br />

and cause profound hypotony: The surgical problem is to close the<br />

cleft and restore the IOP.<br />

How about making a suprachoroidal cleft surgically to treat<br />

glaucoma? This was first described as a treatment by Heine in 1905<br />

and named Cyclodialyis: “eine neue Glaucomoperation”. It works<br />

by causing increased uveoscleral outflow or decreased aqueous<br />

production or both. The contemporary approach to achieving<br />

Cyclodialysis is to insert an engineered device permanently into the<br />

supracoroidal space which also links to anterior chamber aqueous.<br />

Usage of a device is an attempt to control the dosage of cleft. The<br />

surgery is either ab or ex interno and the technology available for use<br />

in NZ is the SOLX gold implant. There is also the Glaukos Supra, the<br />

Transcend Medical CyPass and STARflo competing for this space.<br />

Canaloplasty<br />

Boy racers improve the performance of their cars by taking off the<br />

muffler and increasing the size of the exhaust. This is analogous to<br />

how canaloplasty is meant to work. Injecting viscoelastic into the<br />

Schlemm’s canal will increase the size of the canal and the collector<br />

channel openings. The classic operation is the Viscocanalostomy.<br />

Critics make the point that there is often a visible bleb following<br />

viscocanalostomy supporting a subconjuctival outflow pathway. Ellex<br />

an Australian laser company purchased the canaloplasty business of<br />

the Californian company, iScience Interventional, in 2014. A fiberoptic<br />

catheter is introduced into Schlemm’s canal and viscoelastic is used<br />

to dilate the Schlemm’s canal. There is a video of the procedure at the<br />

Ellex website and favourable results have been published.<br />

Conclusion<br />

It is clear that massive effort is going into improving glaucoma surgery.<br />

Contemporary glaucoma drainage surgery is witnessing greater usage<br />

of engineered solutions i.e. tubes and stents and the shift in practice is<br />

being propelled by randomised controlled trials showing significances<br />

in “safety” indicators rather than neutral efficacy indicators. ▀<br />

References<br />

1. Allingham, R. R., Damji, K. F., Freedman, S. F., Moroi, S. E., Rhee, D. J., & Shields,<br />

M. B. (2012). Shields Textbook of Glaucoma. Lippincott Williams & Wilkins.<br />

2. Arora, K. S., Robin, A. L., Corcoran, K. J., Corcoran, S. L., & Ramulu, P. Y. (2015).<br />

Use of Various Glaucoma Surgeries and Procedures in Medicare Beneficiaries<br />

from 1994 to 2012. Ophthalmology, 122(8), 1615–1624. http://doi.org/10.1016/j.<br />

ophtha.2015.04.015<br />

3. Chihara, E., Nishida, A., Kodo, M., Yoshimura, N., Matsumura, M., Yamamoto, M.,<br />

& Tsukada, T. (1993). Trabeculotomy ab externo: an alternative treatment in adult<br />

patients with primary open-angle glaucoma. Ophthalmic Surgery, 24(11), 735–739.<br />

4. Craven, E. R., Katz, L. J., Wells, J. M., Giamporcaro, J. E., iStent Study Group.<br />

(2012). Cataract surgery with trabecular micro-bypass stent implantation in<br />

patients with mild-to-moderate open-angle glaucoma and cataract: two-year<br />

follow-up. Journal of Cataract and Refractive Surgery, 38(8), 1339–1345. http://<br />

doi.org/10.1016/j.jcrs.2012.03.025<br />

5. Gedde, S. J., Schiffman, J. C., Feuer, W. J., Herndon, L. W., Brandt, J. D., Budenz, D. L.,<br />

Tube Versus Trabeculectomy Study Group. (2012). Treatment outcomes in the Tube<br />

Versus Trabeculectomy (TVT) study after five years of follow-up. American Journal<br />

of Ophthalmology, 153(5), 789–803.e2. http://doi.org/10.1016/j.ajo.2011.10.026<br />

6. Malvankar-Mehta, M. S., Iordanous, Y., Chen, Y. N., Wang, W. W., Patel, S. S.,<br />

Costella, J., & Hutnik, C. M. L. (2015). iStent with Phacoemulsification versus<br />

Phacoemulsification Alone for Patients with Glaucoma and Cataract: A Meta-<br />

Analysis. PloS One, 10(7), e0131770. http://doi.org/10.1371/journal.pone.0131770<br />

7. Pfeiffer, N., Garcia-Feijoo, J., <strong>Mar</strong>tinez-de-la-Casa, J. M., Larrosa, J. M., Fea, A.,<br />

Lemij, H., et al. (2015). A Randomized Trial of a Schlemm’s Canal Microstent with<br />

Phacoemulsification for Reducing Intraocular Pressure in Open-Angle Glaucoma.<br />

Ophthalmology, 122(7), 1283–1293. http://doi.org/10.1016/j.ophtha.2015.03.031<br />

8. Yuan, F., Li, L., Chen, X., Yan, X., & Wang, L. (2015). Biodegradable 3D-Porous<br />

Collagen Matrix (Ologen) Compared with Mitomycin C for Treatment of Primary<br />

Open-Angle Glaucoma: Results at 5 Years. Journal of Ophthalmology, 2015(9),<br />

637537–7. http://doi.org/10.1155/2015/637537<br />

* Dr <strong>Mar</strong>k Donaldson is a cataract and glaucoma surgeon<br />

who has a private/public practice in Auckland. He is the<br />

founding partner of Eye Doctors with rooms at Ascot<br />

Hospital. He learnt the subtleties of trabeculectomy<br />

surgery in London participating in Peng Khaw’s TGFbeta<br />

study and completing a 12-month glaucoma fellowship<br />

with Clive Migdal at the Western Eye Hospital. He is<br />

an experienced angle surgeon and uses both iStent or<br />

Hydrus in combination with cataract surgery to lower IOP<br />

surgically as an alternative to trabeculectomy. Safe and<br />

reliable glaucoma surgery is his priority.

ANZGIG’s brilliance comes to Auckland<br />


The 28th ANZGIG (Australia and New Zealand Glaucoma Interest<br />

Group) annual meeting was held this year in the heart of<br />

Auckland city, at the Stamford Plaza on February 12–13, <strong>2016</strong>.<br />

Delegates from across New Zealand, the UK, Singapore and the US<br />

were in attendance to enjoy the meeting that boasted both a strong<br />

clinical and scientific programme, featuring an array of both national<br />

and international specialists at the top of their field. These included<br />

keynote speaker Dr George Spaeth from the Wills Eye Hospital in<br />

Philadelphia; Dr Peter Shah from the Birmingham & Midland Eye<br />

Centre in the UK; Assistant Professor Ivan Goldberg of Eye Associates<br />

in Sydney; and Assistant Professor Anne Brooks from the Royal<br />

Victorian Eye and Ear Hospital in Melbourne.<br />

ANZGIG Cases<br />

After welcome drinks on the Thursday evening, the meeting proper<br />

started on the Friday morning with ANZGIG Cases. The session was<br />

chaired by Associate Professor Paul Healy, from the University of<br />

Sydney, and included a panel of experts including Assistant Professors<br />

Anne Brooks and Graham Lee, Dr Peter Shah and Dr <strong>Mar</strong>k Walland.<br />

Cases were presented from specialists from various centres. Each<br />

highlighted a particularly complex case and the difficulty encountered<br />

in its management. The panel and the audience were then asked for<br />

their input into the ways in which they may have managed things<br />

differently. This interesting session highlighted not only the supportive<br />

and congenial nature of the ANZGIG forum, but that even the most<br />

experienced clinicians can be challenged by tricky cases, though if we<br />

are thorough and stick to the basics the answer usually finds it way<br />

through.<br />

Sessions such as these are valuable tools for those willing to<br />

put themselves on the spot so that others may learn from their<br />

experiences.<br />

Drs Michael Merriman, Keith Small, Hussain Patel and Shenton Chew<br />

Dr Julian Rait with Professor Helen Danesh-Meyer and keynote speaker<br />

Dr George Spaeth<br />

The Ronald Lowe Lecture<br />

The highlight of the morning sessions was this year’s recipient of the<br />

Ronald Lowe Medal and presenter of the Lowe Lecture, Dr George<br />

Spaeth.<br />

Spaeth has been at the forefront of ophthalmic research, particularly<br />

in glaucoma for the last 40 years and his lecture, A tale of two cities:<br />

which we chose determines our destiny, was in two words—thought<br />

provoking—and I don’t think I can go on without adding a third—<br />

brilliant.<br />

To say that Spaeth is inspiring is only touching the surface. He<br />

challenged his audience to think. As health professionals we are all<br />

too ready to treat ‘the disease’ and in doing so we forget the real<br />

reason we became a health professional—to help people. With the<br />

two cities of the medical world—the city of the patient and the city of<br />

the caregiver—Spaeth reminded us that as medical professionals the<br />

most important type of ‘evidence’ we need to consider when caring for<br />

patients is when the patient says ‘I hurt’. This, he paused, is in fact more<br />

significant than the results of any meta-analysis.<br />

He then went on to illustrate the mentality of the ‘old school’ medical<br />

profession by discussing the evolution of glaucoma. Once thought<br />

of as a disease that made all, eventually, go blind. As such patients<br />

were often over-treated with the negative effects of the treatment<br />

outweighing the disease itself. Quality of life was not understood or<br />

taken into consideration in those days, he explained. He went on to<br />

share with us a poem by Ann Spaeth, the final verse: “…but if you move<br />

or speak you will only hear yourself”.<br />

Spaeth concluded the lecture with this final ‘pearl’—cater the<br />

treatment to the patient that sits in front of you, don’t just treat the<br />

disease.<br />

A research overview<br />

The afternoon provided an overview into the expanse of research<br />

within the field of glaucoma. Chaired by Assistant Professor Brooks and<br />

New South Wales glaucoma surgeon and neuro-ophthalmologist Dr<br />

Mitchell Lawlor, this session gave a taste of the high calibre of research<br />

taking place across the Pacific, Asia and the UK.<br />

Professor Jonathon Crowston, ANZGIG president and the Ringland<br />

Anderson Professor of Ophthalmology at the University of Melbourne,<br />

discussed his team’s research into the nature of injured vs. healthy<br />

retinal ganglion cells (RGC) and their capacity for recovery and<br />

the potential for vision recovery in glaucoma. Work from his team<br />

demonstrated that RGCs do not necessarily die after an injury, but<br />

can recover, function even, following prolonged periods of functional<br />

loss. Dr Jayant Iyer, an adjunct clinical research fellow at the Singapore<br />

Eye Research Institute, gave a video presentation with a memorable<br />

comical twist on the various techniques for Goniosynechialysis—Tap,<br />

sweep and ‘Tweep’ techniques—and discussed a case of conjunctival<br />

microangiopathy secondary to diabetes presenting as a red eye five<br />

years after a glaucoma implant. He concluded that a number of factors,<br />

including ocular ischemia, played a role for the modified clinical<br />

features.<br />

The final session of day chaired by Dr Jo Koppens, from the Milford<br />

Eye Clinic in Auckland, continued on a similar theme with delegates<br />

presenting the latest research from various centres. Auckland<br />

ophthalmologist Dr Abdul-Rahman discussed the ‘Ebbinhaus’s illusion<br />

in the evaluation of the optic disc. Glaucoma Fellow at Royal Victorian<br />

Eye & Ear Hospital in Melbourne Dr Nathan Kerr and I both discussed<br />

the findings of our respective centres’ research into Selective Laser<br />

Trabeculoplasty and its affects on intraocular pressure spikes and<br />

fluctuations during the water drinking test (WDT), sparking much<br />

discussion from the audience to the factors that may have contributed<br />

to differing results.<br />

Melbourne glaucoma surgeon Dr Simon Skalicky concluded the<br />

afternoon with his research into the ‘Activity Limitation in glaucoma:<br />

objective assessment by the Cambridge visual function test’. Skalicky<br />

discussed the findings of a cross-sectional study to evaluate a<br />

computer-based objective simulation of activity limitation related to<br />

glaucoma—The Cambridge Visual Function Test (CVFT)—concluding<br />

the CVFT may prove a useful to simulate activity limitation related to<br />

glaucomatous visual loss.<br />

The Gillies Lecture<br />

Highlights from Saturday included the presentation of the Gillies<br />

Medal to Professor Helen Danesh-Meyer, Auckland-based ophthalmic<br />

surgeon, clinician-scientist and ANZGIG <strong>2016</strong> convenor, and her<br />

subsequent Gillies Lecture New adventures of an Old Flame: the role of<br />

inflammation in the optic nerve and retina.<br />

Anyone who has had the privilege of hearing Danesh-Meyer speak<br />

about her research will understand when I say – passionate, inspiring<br />

and of course brilliant.<br />

Danesh-Meyer began with introducing the founders of<br />

neurobiology—Santiago Ramon Cajal (1852-1934) and Camillo<br />

Golgi (1843-1934)—the once great friends turned foes, with what<br />

were classically described as ‘differing views’ on the complexity of<br />

the neuron, though both went onto eventually share the Nobel Prize<br />

in 1906. The question Danesh-Meyer raised, however, was were<br />

their differing views in actual fact different at all? She then took the<br />

audience through a journey of her team’s research into Conexin 43 and<br />

the evolving view that the glial cell is more than a supportive bystander<br />

in the neurological community and is in actual fact an integral part,<br />

and perhaps even the key, to preventing damage and enabling recovery<br />

in glaucomatous disease.<br />

Breaking bad habits<br />

Spaeth followed with his presentation Old habits we must break:<br />

systematic bias, irrelevant surrogates and C/D; new ones we must<br />

start: honesty, SPARCS and DDLS.<br />

Here, once again Spaeth captivated his audience, outlining some of<br />

the idiosyncrasies within the practice of glaucoma and medicine as a<br />

whole. Bias in medicine, Spaeth pointed out, with our ‘research hat’<br />

we strive to avoid increasing the ‘quality’ of our research, but with our<br />

‘clinical hat’ we all too easily forget and overlook bias. He then went<br />

on to discuss the irrelevance of the cup-to-disc (C/D) ratio, something<br />

that has been agreed on by clinicians in the US, but yet is still used in<br />

clinical practice due to demand for its inclusion in patient assessment<br />

for insurance purposes. Spaeth pointed out that the C/D ratio once<br />

consider pathognomonic for glaucoma is now understood to hold less<br />

relevance, if any, on its own than once classically thought. Reminding<br />

the audience that it’s not the C/D ratio, but the ‘pattern’ of the disc<br />

that makes glaucoma, Spaeth then lead into the DDLS – Disk Damage<br />

Likelihood Scale, a way to evaluate the Rim/disk ratio, assessing the<br />

‘narrowest width rim’ using a scale from 1 – 10.<br />

Spaeth demonstrated, with examples, the point that disc shapes<br />

can vary and the factor that determines the DDLS stage is not the disc<br />

shape but the narrowest width of the rim, which can demonstrate<br />

the thinning associated with glaucomatous loss of the retinal nerve<br />

fibre layer.<br />

He concluded with discussing the Glaucoma Graph, which<br />

essentially lays out the DDLS into green (safe), yellow (possible<br />

progression) and red (RNFL damage) areas. He used this graph to plot<br />

the progression of his patients’ disease and simultaneously show his<br />

patients the pattern of their progression to encourage compliance.<br />

As Spaeth explained, the Glaucoma Graph was a way to simplify<br />

glaucoma—everyone understands the universal meaning of green<br />

(safe), yellow (caution), red (danger).<br />

Emerging concepts<br />

The afternoon session boasted another demonstration of emerging<br />

concepts and surgical technique in glaucoma.<br />

UK consultant ophthalmologist Professor Peter Shah kicked off the<br />

session with Optimizing High Risk Surgery, where he broke down<br />

his method, step-by-step, for simplifying and minimizing the factors<br />

associated with ‘high-risk’ glaucoma surgery.<br />

Dr <strong>Mar</strong>k Donaldson, a consultant ophthalmologist with Eye Doctors<br />

Article author and ANZGIG presenter Kaliopy Matheos, Hannah Kersten and<br />

Dr Kevin Liu<br />

Dr Guy D’Mellow, Glaucoma Australia’s Geoff Pollard and Dr David Manning<br />

and Greenlane Hospital in Auckland, discussed his experience with<br />

the intricacies of ‘Glaucoma Angle Surgery and Schlemm’s Canal<br />

Cannulation’; while Assistant Professor Graham Lee from Brisbane<br />

discussed ‘MIGS’ and entertained the audience with footage from his<br />

own MIGS procedures using iSTENT and Hydrus. He concluded, after<br />

reviewing 80 procedures, that MIGS provides a further option for<br />

patients who are not good candidates for trabeculectomy and who<br />

have failed on maximal medical treatment.<br />

New South Wales ophthalmologist Dr David Manning went<br />

onto present his experience with iSTENT over a 12 month period<br />

– specifically discussing the postoperative IOP reduction and<br />

medication use. He demonstrated that cataract surgery combined<br />

with iSTENT placement could result in IOP reductions, which were<br />

sustained for a 12 month period. He concluded the ‘iSTENT’ should<br />

be considered in patients with glaucoma undergoing cataract<br />

surgery to assist with IOP reduction.<br />

Presentation awards<br />

The overall prize for the best presentation by a junior ophthalmologist<br />

was awarded to Lewis Fry who presented, Injury and recovery of retinal<br />

ganglion cells (RGC): the role of structural plasticity of the axon initial<br />

segment (AIS) following and acute intraocular pressure challenge in<br />

mice. His presentation included data demonstrating age-related, but<br />

reversible structural plasticity of the AIS of RGCs following induced<br />

injury in older mice.<br />

Honorable mention was also given to the presentation by Dr Rachel<br />

Goh, The Visual function Questionnaire – Utility index: does it measure<br />

glaucoma-related preference-based status? Rachel was commended for<br />

the way in which she took a particularly complex topic and managed to<br />

communicate this with simplicity to her audience.<br />

Clinical pearls<br />

The final stage of the conference focused on ‘Clinical Pearls’. The<br />

session, chaired by Danesh-Meyer, asked a panel of speakers to share<br />

with the audience their Clinical Pearls: Mistakes, Lies & Lessons and<br />

address three questions: my most valuable clinical pearl; a mistake<br />

I have made in my career; and something that is written in the<br />

textbooks that I think is wrong.<br />

Goldberg, Brooks and Spaeth were all given the challenge and all had<br />

the audience hanging on to their every word with their responses on<br />

what made these three brilliant minds click and the events that had<br />

shaped their career paths. There were many amazing words of wisdom,<br />

but I’ll leave you with a few ‘key pearls’:<br />

1. The Ingredients for a successful doctor-patient relationship:<br />

collaboration, empathy and appropriate use of power. (Goldberg)<br />

2. Worrying too much about things I cannot change – ‘worrying is a<br />

misuse of the imagination’. (Brooks)<br />

3. The primary purpose in life is to love – love what you do and love<br />

your patients. Our goal in treating, should not be to ‘treat the<br />

disease’ but to ‘treat the patient’ – helping them to achieve the<br />

greatest quality of life. (Spaeth)<br />

In conclusion<br />

Overall this was, I have to say, one of the most inspiring, informative<br />

and enjoyable conferences I have attended. Professor Helen Danesh-<br />

Meyer and her organising committee put together a fantastic<br />

meeting at a wonderful venue with an extremely high calibre of both<br />

International and national guest speakers. There was a great range of<br />

clinical topics and a good balance of senior and junior participation.<br />

It left me with the thought that as the practice and understanding<br />

of the complexities of glaucoma advances, we must always keep in<br />

mind; that as clinicians we became who we are and we do what we<br />

do to ‘help people’ and sometimes simply ‘curing the disease’ is not<br />

fulfillment of this cause. It’s important to have forums such as this<br />

once in a while, merging the scientific and ethical world, to remind of<br />

us of that point. ▀<br />

* Dr Kaliopy Matheos is a trainee ophthalmology registrar, currently working at<br />

Greenlane Clinical Centre, Auckland<br />

<strong>Mar</strong>ch <strong>2016</strong><br />





<strong>2016</strong> SCHOLARSHIPS<br />

Techno<br />

I’ve always been interested in<br />

technology. As a child I shunned fiction<br />

and apart from the Hardy Boys books<br />

and Louis L’Amour westerns most of my<br />

reading was non-fiction. I loved books<br />

about snakes, rocks, nature and much<br />

more. I read pretty much every Popular<br />

Science magazine from the 1950s onward<br />

as well as National Geographic, from cover<br />

to cover. In later years, I enjoyed Scientific<br />

American and Omni magazine. I was<br />

also into photography and had my own<br />

darkroom. When still quite young, I was<br />

mad keen on the amazing How & Why<br />

Wonder Book of... series. I still remember<br />

to this day building my first computer<br />

based on the How and Why of Computers.<br />

It was simply a torch battery with a globe,<br />

some interconnecting wires and a switch.<br />

It explained the binary system very well.<br />

When the switch was closed and the lamp<br />

lit up, that was a binary “1”. When the<br />

switch was open that represented a binary<br />

“0”. This is of course what digital info and<br />

computers are based on: a series of binary<br />

numbers—packed into “data packets” and<br />

transferred across a bus in a computer,<br />

over a network or the Internet—then<br />

decoded, magically turning all these zeros<br />

and ones into an image, PDF, video or<br />

whatever.<br />

We computerised our practice in South<br />

Africa in 1981—before Windows and at<br />

the very start of PCs. In those days we ran<br />

a specially written optometric package<br />

running on the CP/M operating system. It<br />

was all monochrome screens and menudriven<br />

lists. In the mid-1990s in New<br />

Zealand, we upgraded our practice to a<br />

server-based integrated system, so that we<br />

could view all data, topographies, fields<br />

and data on any computer in the practice<br />

and we never looked back. It was one of<br />

the first integrated optometric systems<br />

and was soon emulated by many.<br />

I’m still amazed on a daily basis when I<br />

use my iPhone. That this super thin and<br />

lightweight phone can shoot HD videos<br />

and amazing images through a tiny lens<br />

only about 3 mm in diameter astounds me,<br />

especially so after having lugged a huge<br />

bag around for my SLRs and lenses during<br />

the 1970s and ‘80s. The sheer computing<br />

power and functionality is unbelievable. I<br />

use dozens of apps, programs, email, social<br />

media and much more, every day. I can<br />

literally run my life with it.<br />

The only thing I can’t yet run is my wife,<br />

but I hope there will be an app for that<br />

soon…<br />

My wife Karen proofreads my column<br />

and she added this comment in the edited<br />

version as a retort. “Alan just doesn’t know<br />

about the App that I use to run him, it’s<br />

called ‘F&S’”.<br />

Touché` and thanks for the heads up.<br />

Back to the optical world…<br />

Despite all this amazing miniaturisation<br />

and functionality there are limits as to<br />

what we can achieve with the traditional<br />

ground glass, milled or moulded plastic<br />

lenses we are all so familiar with. There are<br />

also limits as to the maximum resolution<br />

attainable with traditional optics.<br />

We’ve seen how scanning lasers allow us<br />

to obtain superb OCT images and superwidefield<br />

retinal images. Femtosecond<br />

lasers allow for sensational corneal<br />

sculpting and assist in cataract surgery.<br />

There are some true geniuses behind the<br />

scenes that create the fantastic lasers and<br />

software that allows for all this Sic-fi stuff.<br />

I don’t think they get the recognition<br />

they deserve.<br />

More often the kudos is attributed to the<br />

operators.<br />

Nano-optics & photonics<br />

Electro-optics and more specifically<br />

photonics and nano-optics, are allowing<br />

us to go beyond the physical and optical<br />

limits that traditional optics imposes.<br />

One of these barriers has been the socalled<br />

diffraction limit: simply put, nature<br />

and the laws of physical-optics limit the<br />

maximum resolution achievable.<br />

In recent times some clever scientists<br />

found ways to go beyond this and<br />

demonstrated how this was achievable.<br />

Like many emerging technologies these<br />

solutions were complex and expensive, nor<br />

suited to mass production or portability.<br />

Zheng et al have now found a way to<br />

make this technology less expensive,<br />

portable and scalable for mass production.<br />

They show this is their recent paper, Highly<br />

efficient and ultra-broadband graphene<br />

oxide ultrathin lenses with threedimensional<br />

subwavelength focusing.<br />

If you think that’s a mouthful then dig<br />

into their abstract where they explain the<br />

basic premise:<br />

Nanometric flat lenses with threedimensional<br />

subwavelength focusing<br />

are indispensable in miniaturised optical<br />

systems. However, they are fundamentally<br />

challenging to achieve because of the<br />

difficulties in accurately controlling<br />

the optical wavefront by a film with<br />

nanometric thickness. Based on the unique<br />

and giant refractive index and absorption<br />

modulations of the sprayable graphene<br />

oxide thin film during its laser reduction<br />

process, we demonstrate a graphene oxide<br />

ultrathin (~200nm) flat lens that shows<br />

far-field three-dimensional subwavelength<br />

focusing (λ3/5) with an absolute focusing<br />

efficiency of >32% for a broad wavelength<br />

range from 400 to 1,500nm. Our flexible<br />

graphene oxide lenses are mechanically<br />

robust and maintain excellent focusing<br />

properties under high stress. The simple<br />

and scalable fabrication approach enables<br />

wide potential applications in on-chip<br />

nanophotonics. The wavefront shaping<br />

concept opens up new avenues for easily<br />

accessible, highly precise and efficient<br />

optical beam manipulations with a flexible<br />

and integratable planar graphene oxide<br />

ultrathin film.<br />

Gizmag recently covered this in more<br />

layman friendly terms.<br />

Resolution revolution<br />

It seems that this technology<br />

could revolutionise things like smart<br />

phone cameras, space telescopes and<br />

microscopes.<br />

In the not too distant future we may see<br />

this revolutionary technology applied to<br />

smart contact lenses and corneal inlays<br />

that could help people with low vision,<br />

among other things. I would also think it<br />

lends itself to upping the ante in retinal<br />

chip and bionic eye projects. Similarly it<br />

could be included in IOLs and possibly<br />

solving the presbyopia problem? It should<br />

also lend itself to significantly increasing<br />

the resolution of OCT, widefield retinal<br />

imaging systems and much more.<br />

Our insatiable human imagination will<br />

conjure up many applications, as it did this<br />

technological leap.<br />

No doubt the military skunk works<br />

will also see potential for combatants,<br />

aircraft and drones and would no doubt<br />

take advantage of the chips’ infrared<br />

capabilities.<br />

The possibilities are seemingly endless.<br />

So we go from my first cigarette-pack<br />

sized transistor radio my parents brought<br />

back from EXPO ’67, Montreal, Canada<br />

to the cassette tape of my teens, to my<br />

first Rockwell scientific calculator at high<br />

school and the wonderful HP41CV, that<br />

was so useful in optometry school. I also<br />

well recall the first kitchen-table sized<br />

autorefractors that were among the<br />

first instruments to incorporate LEDs,<br />

optics and electronics in the late ‘70s. As<br />

mentioned we had our first minicomputers<br />

by 1980, which became the ubiquitous<br />

desktop PCs that nowadays pretty much<br />

run the world.<br />

Today we have the iPhone.<br />

Tomorrow?<br />

Technology is fantastic. It still excites me<br />

as it did when I was a young child.<br />

Remarkable stuff. ▀<br />

The Trustees of the Snowvision Charitable Trust<br />

announce the offer of three scholarships – two for<br />

New Zealand optometrists (with one scholarship<br />

funded by the NZAO) and one for a final year<br />

student completing the BOptom – to undertake<br />

a period of four weeks clinical study at the State<br />

College of Optometry, State University of New York<br />

(SUNY), New York. The successful applicants will<br />

be expected to spend a minimum of forty hours<br />

per week in the Optometry Department pursuing<br />

clinical studies as approved by the Trustees.<br />

The scholarship is for a maximum of NZ$7,000<br />

and covers one return advance purchase economy<br />

airfare from Auckland to New York and the tuition<br />

fees at SUNY. Assistance in finding accommodation<br />

will be given if needed.<br />

The conditions of the scholarship include:<br />

The optometrist must be in full-time practice in<br />

New Zealand and must practise optometry fulltime<br />

in New Zealand for two years following<br />

their return from SUNY. The student must<br />

practise optometry in New Zealand for two<br />

years at the completion of their degree.<br />

The holders must provide a written report of their<br />

time at SUNY to the Trustees within two months<br />

of their return.<br />

The holders must be prepared to give a brief (five<br />

minute) report to the Snowvision Down Under<br />

conference in August, 2018 in Queenstown.<br />

The holders must agree to their report, either in<br />

whole or in part, being published in NZ Optics<br />

magazine and elsewhere at the discretion of<br />

the Trustees.<br />

Requests for application forms should be sent to:<br />

Snowvision Charitable Trust<br />

PO Box 6195<br />

Dunedin<br />

Fax: 03 477 3444<br />

Email: hcaithness@xtra.co.nz<br />

Applications will close on May 31, <strong>2016</strong>. The<br />

decision of the Trustees will be final and in the<br />

event of there being no satisfactory applicant,<br />

no scholarship will be awarded. Optometrists<br />

practising with either of the Trustees are<br />

excluded from applying.<br />

Hamish Caithness<br />

Trustee<br />

David Robinson<br />

Trustee<br />

Modern design meets urban life<br />

Austrian frame manufacturer Silhouette<br />

International is launching neubau, a new<br />

eyewear brand, in June this year.<br />

Named after the seventh district of the Austrian<br />

capital Vienna, the company says the new brand<br />

embodies the spirit you’d find in the “buzzing trendy<br />

quarters of many of the world’s major cities.”<br />

“The Viennese district is an archetypal example<br />

of all those exciting, rapidly evolving creative urban<br />

districts around the world that hold the same kind<br />

of special attraction. This attitude to life has now<br />

become the inspiration behind the name for a new<br />

global brand of spectacles: neubau eyewear.”<br />

Aimed at the millennial generation, the new<br />

brand was showcased for the first time at the OPTI<br />

trade fair in Munich in January. The worldwide<br />

launch in June will include 12 models in six colours<br />

each, with the first neubau sunglasses collection to<br />

follow in October <strong>2016</strong>.<br />

Silhouette has always stood for simple elegance,<br />

high value materials and consistent quality, said CEO<br />

Daniel Rogger, so it’s good to be able to capture the<br />

enthusiasm of a new audience for a product whose<br />

strength lies in more than just modern design.<br />

“neubau eyewear marks the perfect addition to<br />

the brand portfolio of our company. High quality<br />

spectacles made in Austria, perfectly suited to the<br />

requirements of discerning customers.”<br />

Daniel Liktor, Silhouette’s neubau business<br />

manager, added that in an appealing way neubau<br />

eyewear reflects the recent zeitgeist of eyewear<br />

fashion. “It is inspired by young, creative and<br />

contemporary Vienna and can be seen as an homage<br />

to all urban trendy areas as well as those who live<br />

and act in them.”<br />

Silhouette distributor Euro Optics will be the<br />

exclusive distributor for the neubau range in<br />

New Zealand. ▀<br />

18 NEW ZEALAND OPTICS <strong>Mar</strong>ch <strong>2016</strong>

John Nicola’s runs for NVRI<br />

Optique Line’s John Nicola in action in 2012<br />

John Nicola, Optique Line’s founder and<br />

managing director, is to compete in the gruelling<br />

<strong>Mar</strong>athon des Sables for the second time<br />

and has committed his fundraising efforts to the<br />

National Vision Research Insitute (NVRI) in Australia.<br />

“The time has come to venture back to the<br />

Moroccan desert to compete in this year’s ultradesert<br />

marathon. The <strong>Mar</strong>athon des Sables is<br />


considered the toughest footrace on the planet.<br />

With the support of my family, I am back in<br />

training, hoping to get in the best shape to face<br />

this challenging event,” says Nicola.<br />

The event kicks off on April 10. For more<br />

information or to donate, go to:<br />

www.facebook.com/JohnNicolaMDS<strong>2016</strong>/<br />

app/190322544333196/<br />

FOR SALE<br />

Beautiful brushed aluminium frame display, holds 312 frames. Plus lockable frame or sunglass<br />

display racks, holds 96 sunglasses/frames. Also Gatehouse internally illuminated Eye Chart. Perfect<br />

for practices wanting to upgrade their frames displays or a newly opening practice. Andrea Moore<br />

Sunglass display shelves also for sale.<br />

Contact <strong>Mar</strong>k at 027 3806171 or focusoptom@clear.net.nz.<br />



06.05.1938 - 23.01.<strong>2016</strong><br />

Former Tauranga optometrist Lynn Coker died<br />

on January 23 following a long illness. Lynn<br />

will be remembered for his sense of humour,<br />

thoughtfulness and the outrageous things he<br />

used to say. He retired in 2005 after nearly 40<br />

years of practising.<br />

Born and raised in Taumarunui, Coker’s career<br />

got off to a rather inauspicious start as he was<br />

expelled from school. It was whilst he was<br />

shepherding for two years, that he decided he<br />

wanted to do more with his life so undertook<br />

University Entrance by correspondence, financing<br />

himself with a variety of jobs. This was followed<br />

by two years doing Medical Intermediate at the<br />

University of Otago after which he decided to<br />

swap dentistry and pursue a career in optics. He<br />

achieved his Diploma in Optometry in 1965 and<br />

worked in Wellington and then Hastings for two<br />

years before venturing to Tauranga. It was here<br />

he purchased a practice owned by Bob Abbott in<br />

1967. Many in the industry will recall how Coker<br />

used to arrive at 6am each morning to edge<br />

lenses, went home for breakfast, then returned<br />

for a day’s work - a regime that continued for<br />

years.<br />

Some period later his earlier shepherding<br />

experience brought pangs of longing to become<br />

closer to the land. This led him to establish a<br />

deer farm, which he ran alongside his optometry<br />

practice for a number of years, before selling the<br />

farm in 1991.<br />

With his practice growing, Coker took on<br />

a partner, Albert de la Hunt, to join him and<br />

the practice was renamed Vision House<br />

Optometrists.<br />

Respecting each other’s qualities, Coker and<br />

de la Hunt had a great partnership for 10 years<br />

until Coker was forced into retirement due to<br />

poor health. The practice then became known as<br />

Fraser Street Optometrists.<br />

Coker is survived by his accomplished artist<br />

wife Jenny and their three children, Belinda,<br />

Brent and Rachel, and two grandchildren. ▀<br />

Younger Optics appointment<br />

Lens company Younger<br />

Optics has appointed<br />

Craig Johnston as the new<br />

Australia and New Zealand sales<br />

and marketing manager.<br />

Johnston has been in the<br />

optical industry since 1983,<br />

starting his career as an<br />

optical mechanic and qualified<br />

dispenser. Since then he has<br />

held various roles including<br />

key account manager, sales<br />

consultant, national sales<br />

manager and, more recently,<br />

national training and<br />

development manager for Hoya<br />

Vision Care Australia.<br />

Johnston replaces Sam Crooke<br />

and before that Trevor Inglis<br />

who retired at the end of last<br />

year after a ten-year tenure with<br />

Younger Optics. ▀<br />

Younger’s new ANZ sales &<br />

marketing manager Craig Johnston<br />


Choose the work/lifestyle balance option. Rotorua is the place to be. Either a part-time, or preferably, a<br />

full-time position. April start date, or sooner. We have:<br />

• good equipment<br />

• an experienced team of support staff<br />

• and a wide ranging patient base<br />

You will have:<br />

• a passion for community based optometry,<br />

• good time management and teamwork skills<br />

The salary package will meet the market to reflect experience and workload.<br />

The full-time position also has a shareholding opportunity. In the first instance contact Celeste Raisbeck<br />

dir.rotorua.nz@specsavers.com or after hours 021 759 695.<br />


We are looking for a motivated and energetic Dispensing Optician or experienced Optical Assistant<br />

who has exceptional customer service and sales skills and is committed to upholding our practice<br />

philosophy of developing and maintaining long-term customer relationships. We are a wellestablished,<br />

busy and successful independent optometry practice in Wellington’s CBD.<br />

The successful applicant will:<br />

• Display exceptional customer service skills and be committed to providing excellent patient care<br />

• Have excellent communication skills<br />

• Have confidence in selling high-end products and have a proven sales record<br />

• Be motivated, willing to learn and committed to ongoing learning<br />

• Be well presented and have an eye for fashion<br />

• Be competent in technical side of fitting lenses and fixing frames and have a passion for<br />

technology<br />

• An ability to glaze would be an asset however training can be given<br />

• Be versatile, friendly and a team player<br />

A dispensing qualification is preferred but we will consider applicants who are still training or those<br />

who have a strong retail, sales and customer service background with previous optical experience and<br />

an understanding of spectacle lens designs and fitting eyewear.<br />

This is a full-time position (Monday to Friday).<br />

If this sounds like you please send your CV with covering letter to vanessa.sercombe@opticians.co.nz.<br />

Alternatively you can call Vanessa on (021) 132 6789 if you have further questions.<br />



<strong>2016</strong> Programme Open for Enrolments!<br />

• The online web-based Professional Education Programme<br />

is approved by the NZ Optometrists & Dispensing Opticians<br />

Board CPD Accreditation Committee for a maximum of 10.5<br />

Clinical Diagnostic (CD) Credits.<br />

• The programme consists of seven cases – each with a case<br />

history, questions and answers for self-directed learning,<br />

followed by an associated web-based examination.<br />

• Successfully passing all seven cases awards the maximum of<br />

10.5 CD credits.<br />

While mainly directed at optometrists, the programme is open to<br />

any of those in the eye health field, including orthoptists, nurses<br />

and technicians.<br />

For further information please visit www.glaucoma.org.nz<br />

<strong>Mar</strong>ch <strong>2016</strong><br />




ON pAgE 19<br />

Need a locum?<br />

Call Bharat Raniga, locum optometrist, on<br />

021 424 253 or email: bharatraniga@yahoo.com<br />

practicE for salE<br />

Get double-digit earnings without the sweat and toil of a CBD<br />

location. Enjoy the superior work-life balance of the countryside,<br />

while still within an easy drive of civilisation in downtown<br />

Auckland. Ideally suited to an optometrist breaking out on their<br />

own, or breaking back into the business after maternity leave or<br />

OE, or a dispenser-optometrist team. Yes, double-digit earnings,<br />

and potential for even more growth. If this sounds like something<br />

you’d like to pursue, please apply in strictest confidence c/- NZ<br />

Optics, info@nzoptics.co.nz Code PFSS1.<br />


TEL:(09) 486-2070 MOB:(0274) 798-798<br />

Email: tony.maddocks@xtra.co.nz<br />

bEgat WantED<br />

Berkley Glare & Acuity Tester (BEGAT) wanted. Contact c/- NZ<br />

Optics, info@nzoptics.co.nz, Code: BGT1.<br />

EquipMEnt for salE<br />

Topcon Chair and stand, phoroptor, slit lamp, keratometer,<br />

hydraulic table, projector, NCT, Matrix, trial lens set— all in good<br />

condition. Contact c/- info@nzoptics.co.nz, Code: EQFS12<br />

looking for a priME<br />

optoMEtrist!<br />

Great opportunity for a full-time optometrist in an independent,<br />

family-owned business in New Plymouth. Known for their superb<br />

service and extremely helpful team (yes, they have won awards<br />

for it!) they really want someone who “gets their vision”.<br />

They have all the latest technology, including a Zeiss OCT/Camera<br />

and very well equipped exam room and are led by an extremely<br />

experienced Dispensing Optician.<br />

What’s unique about this practice is the loyal customer base and<br />

the amount of referrals they get. This is not a High Street “look<br />

at me” business. They really do like their customers and go out of<br />

their way to help.<br />

The good news about this role is it’s not an immediate start and<br />

no late nights or weekends. They are searching far and wide for<br />

the right person to come and join them in June of this year. So,<br />

if you are thinking of moving to “the best place to live” in New<br />

Zealand then now’s the time to start planning.<br />

Salary is in line-of-sight of market rates. For details and to arrange<br />

an interview contact fitzroyoptom@xtra.co.nz or phone Michael<br />

at 027 758 4974.<br />

salEs agEnt WantED<br />

for south islanD anD WEllington<br />

Optique Line NZ is seeking an enthusiastic, self-motivated sales<br />

agent to service our existing client base as well as seeking new<br />

opportunities to grow our market share in the South Island as<br />

well as Wellington.<br />

The successful candidate will be working alongside our National<br />

Sales Manager. Industry experience is required, whether as a sales<br />

representative or from a dispensing background.<br />

We encourage persons seeking to fill this role to be currently<br />

working in the industry, and are looking for additional<br />

opportunities.<br />

Our extensive portfolio of brands includes Stepper Eyewear and<br />

Convertibles, which are well respected and established in the<br />

New Zealand market, backed up by marketing support and a first<br />

class customer service team. Generous commissions payable.<br />

If you wish to be a part of a progressive company, then please<br />

forward your CV to employment@optiqueline.com.au.<br />

EvEr consiDErED Working in<br />

tasMania, australia?<br />

Our client is an independent optical company based in Tasmania<br />

with 13 practices across the state. They pride themselves on<br />

being “Totally Tasmanian” and offer local, friendly service with a<br />

genuine commitment to customer value and product quality.<br />

Established 20 years ago, our client is now one of the most<br />

successful optical businesses in Tasmania, now employing 18<br />

Optometrists.<br />

A position is now available for an experienced optometrist to join<br />

the Eyelines team in (Launceston) Northern Tasmania in a full- or<br />

part-time capacity (hours and days can be negotiated).<br />

Ideally you will have two to four years’ experience and be TPA<br />

endorsed, but our client has communicated they are open to<br />

enquiry from graduates.<br />

Tasmania offers fantastic lifestyle opportunities, an abundance<br />

of natural scenic wonders including beaches, waterfalls, miles<br />

of scenic coastline with great fishing opportunities, and an<br />

abundance of premium vineyards, orchards and pretty riverside<br />

towns. The state has a rich history and is one of the world’s best<br />

outdoor adventure playgrounds.<br />

An attractive package will be offered to the successful applicant<br />

based on experience plus annual payment of OAA fees and an<br />

attractive bonus scheme—they will also assist with relocation<br />

costs.<br />

You will have the opportunity to work with modern testing<br />

equipment and have the support of qualified dispensing staff. You<br />

will have access to high profile retail brands and products, local<br />

Ophthalmology and CPD, rural Optometry opportunities, and will<br />

be a part of a terrific Optometry team.<br />

The ideal start date for this position is <strong>Mar</strong>ch/April <strong>2016</strong>.<br />

If you are looking for a change of scenery and an exciting career<br />

opportunity, please make contact with Stuart Allan to discuss this<br />

opportunity further, (03) 5466-996 or (027) 436-9091<br />

Applications for this position will close at 5pm on Friday <strong>Mar</strong>ch<br />

11 <strong>2016</strong>, please send CV and cover letter to Stuart Allan, OpticsNZ<br />

Ltd, PO Box 1300, Nelson or via email stu@opticsnz.co.nz<br />

20 NEW ZEALAND OPTICS <strong>Mar</strong>ch <strong>2016</strong><br />

<strong>Mar</strong>ch <strong>2016</strong> classified NEW ZEALAND 1

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!